mp:VDraft3.0.0 consolidatie medicatiegegevensMGR addendum: verschil tussen versies
Naar navigatie springen
Naar zoeken springen
Geen bewerkingssamenvatting |
Geen bewerkingssamenvatting |
||
| Regel 1: | Regel 1: | ||
__NUMBEREDHEADINGS__ | __NUMBEREDHEADINGS__ | ||
{{DISPLAYTITLE:Beschikbaarstellen | {{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens MP9 3.0: addendum inhoudelijke gegevens test}} | ||
=Addenda voor inhoudelijke gegevens= | =Addenda voor inhoudelijke gegevens= | ||
==Patiënt | ==Patiënt L. van de XXX_Meijsz== | ||
<section begin= | <section begin=XXX_Meijsz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 18: | Regel 17: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
|style="background-color: white;"| | |style="background-color: white;"|L. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Voorvoegsels | |||
|style="background-color: white;"|van de | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
|style="background-color: white;"| | |style="background-color: white;"|XXX_Meijsz | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Adresgegevens | |||
|style="background-color: white;"|Knolweg 1003 9999ZA Apeldoorn Apeldoorn 157 Nederland 3 Woon-/verblijfadres | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
|style="background-color: white;"| | |style="background-color: white;"|999900821 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
|style="background-color: white;"| | |style="background-color: white;"|27 okt 1985 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | ||
|}<section end= | |}<section end=XXX_Meijsz /><section begin=ALLMBHS_XXX_Meijsz /><section begin=MBH_MBH_300_hybride_voorschrift /> | ||
====Medicamenteuze behandeling | ====Medicamenteuze behandeling MBH_300_hybride_voorschrift ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_hybride_voorschrift_MA | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 49: | Regel 51: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_hybride_voorschrift_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 1 dag om 12:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T + | |style="background-color: white;"|T + 7 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 70: | Regel 72: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Hannie_Huiske|Zorgverlener: Hannie_Huiske]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|TRIMETHOPRIM TABLET 300MG (code = '16020' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|TRIMETHOPRIM TABLET 300MG (code = '39136' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 83: | Regel 85: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T | |style="background-color: white;"|Vanaf T, tot en met T + 7 dagen, 1 maal per dag 2 stuks, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag | |style="background-color: white;"|1 maal per dag 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_hybride_voorschrift (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_hybride_voorschrift_VV | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 102: | Regel 104: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_hybride_voorschrift_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Verstrekkingsverzoek datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 1 dag om 12:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="5"|Auteur | ||
|style="background-color: #E3E3E3;;"| | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Hannie_Huiske|Zorgverlener: Hannie_Huiske]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"| | |style="background-color: white;"|14 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|TRIMETHOPRIM TABLET 300MG (code = '16020' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|TRIMETHOPRIM TABLET 300MG (code = '39136' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Beoogd verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |||
|style="background-color: white;"|MBH_300_hybride_voorschrift_MA | |||
|colspan=" | |||
|style="background-color: white;"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_hybride_voorschrift (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |}<section end=MBH_MBH_300_hybride_voorschrift /><section begin=MBH_MBH_300_hybride_generiekeTA /> | ||
====Medicamenteuze behandeling MBH_300_hybride_generiekeTA ==== | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak 16020 | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 168: | Regel 148: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|16020 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 1 dag om 15:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T + | |style="background-color: white;"|T + 7 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 190: | Regel 170: | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 205: | Regel 176: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T | |style="background-color: white;"|Vanaf T, tot en met T + 7 dagen, 1 maal per dag 2 stuks, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag | |style="background-color: white;"|1 maal per dag 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
| Regel 218: | Regel 189: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|Vooraankondiging_PresciptionID (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_hybride_generiekeTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |}<section end=MBH_MBH_300_hybride_generiekeTA /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="5"|<span id="Hannie_Huiske" title="Intern ID = Hannie_Huiske">Zorgverlener Hannie_Huiske</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgverlener identificatienummer | ||
|style="background-color: white;"| | |style="background-color: white;"|000004449 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Naamgegevens | ||
|style="background-color: white;"| | |style="background-color: white;"|Hannie H. Huiske | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Specialisme | ||
|style="background-color: white;"| | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#huisartsencentrum_Huiske|Zorgaanbieder: huisartsencentrum_Huiske]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Zorgaanbieder identificatienummer | ||
|style="background-color: white;"| | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Organisatie naam | ||
|style="background-color: white;"| | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|<span id="huisartsencentrum_Huiske" title="Intern ID = huisartsencentrum_Huiske">Zorgaanbieder huisartsencentrum_Huiske</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder identificatienummer | ||
|style="background-color: white;"| | |style="background-color: white;"|00003336 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Organisatie naam | ||
|style="background-color: white;"| | |style="background-color: white;"|huisartsencentrum Huiske | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Afdeling specialisme | ||
|style="background-color: white;"| | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
|}<section end=ALLMBHS_XXX_Meijsz /> | |||
==Patiënt B. XXX_Blik== | |||
<section begin=XXX_Blik /> | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="6"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="3"|Initialen | ||
|style="background-color: white;"|B. | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Naamgebruik | ||
|style="background-color: white;"| | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="2"|Achternaam | ||
|style="background-color: white;"| | |style="background-color: white;"|XXX_Blik | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatienummer | |||
|style="background-color: white;"|999900389 [BSN] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geboortedatum | |||
|style="background-color: white;"|13 okt 1963 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Geslacht | ||
|style="background-color: white;"| | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
|}<section end= | |}<section end=XXX_Blik /><section begin=ALLMBHS_XXX_Blik /><section begin=MBH_MBH_300_QA1 /> | ||
====Medicamenteuze behandeling | ====Medicamenteuze behandeling MBH_300_QA1 ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_QA1_MA | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 306: | Regel 289: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 20 dagen om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 20 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 9 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 324: | Regel 310: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 337: | Regel 323: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"| | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_QA1_VV | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 356: | Regel 342: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Verstrekkingsverzoek datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 20 dagen om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |||
|colspan="5"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"| | |style="background-color: white;"|60 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Beoogd verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |||
|style="background-color: white;"|MBH_300_QA1_MA | |||
|colspan=" | |||
|style="background-color: white;"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_QA1_TA | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 416: | Regel 384: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Toedieningsafspraak datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 20 dagen om 09:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 20 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T + 9 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 453: | Regel 421: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"| | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
| Regel 466: | Regel 434: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_QA1_MVE | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 479: | Regel 447: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Medicatieverstrekkings datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 20 dagen om 09:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 498: | Regel 458: | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekte hoeveelheid | |||
|style="background-color: white;"|60 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="4"|Relatie verstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_QA1_VV | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"| | |||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_QA1_MGB | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 539: | Regel 485: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 1 dag om 10:04:23 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Volgens afspraak indicator | ||
|style="background-color: white;"| | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 9 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 573: | Regel 535: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie toedieningsafspraak | |colspan="5"|Relatie toedieningsafspraak | ||
| Regel 593: | Regel 548: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |}<section end=MBH_MBH_300_QA1 /><section begin=MBH_MBH_300_QA2 /> | ||
====Medicamenteuze behandeling MBH_300_QA2 ==== | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_QA2_MA | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 606: | Regel 563: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Medicatieafspraak datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 100 dagen om 08:04 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 100 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 72 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 646: | Regel 597: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag | |style="background-color: white;"|1 maal per dag 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="4"|MBH identificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|colspan=" | |} | ||
|style="background-color: white;"| | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_QA2_VV | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_QA2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekkingsverzoek datum tijd | |||
|style="background-color: white;"|T - 100 dagen om 08:04 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Te verstrekken hoeveelheid | |||
|style="background-color: white;"|300 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Beoogd verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie medicatieafspraak | |||
|style="background-color: white;"|MBH_300_QA2_MA | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_QA2_TA | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 681: | Regel 658: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Toedieningsafspraak datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 100 dagen om 09:04 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 100 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T - 72 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 715: | Regel 695: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 | |style="background-color: white;"|1 maal per dag 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_QA2_MVE | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 734: | Regel 721: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Medicatieverstrekkings datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 100 dagen om 09:04 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |||
|colspan="5"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Verstrekte hoeveelheid | ||
|style="background-color: white;"| | |style="background-color: white;"|300 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Relatie verstrekkingsverzoek | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA2_VV | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatiegebruik MBH_300_QA2_MGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="5" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="5"|Identificatie | ||
|style="background-color: white;"|1 | |style="background-color: white;"|MBH_300_QA2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="5"|Medicatiegebruik datum tijd | ||
|style="background-color: white;"|T - 68 dagen om 12:13:55 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="5"|Gebruik indicator | ||
|style="background-color: white;"| | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Ingangsdatum | ||
|style="background-color: white;"| | |style="background-color: white;"|T - 100 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Einddatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 72 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="6"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Zorgverlener | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="4"| | ||
| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Auteur is zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="5"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="5"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="6"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 millimeter, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag | |style="background-color: white;"|1 maal per dag 10 millimeter | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="6"|Relatie toedieningsafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="5"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |}<section end=MBH_MBH_300_QA2 /><section begin=MBH_MBH_300_QA3 /> | ||
====Medicamenteuze behandeling MBH_300_QA3 ==== | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_QA3_MA | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 860: | Regel 841: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Medicatieafspraak datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 50 dagen om 08:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 50 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T - 11 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 897: | Regel 875: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"| | |style="background-color: white;"|2 maal per dag 50 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_QA3_VV | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 923: | Regel 894: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA3_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Verstrekkingsverzoek datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 50 dagen om 08:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="5"|Auteur | ||
|style="background-color: #E3E3E3;;"| | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="4"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"|T - | |style="background-color: white;"|4000 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Beoogd verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie medicatieafspraak | |||
|style="background-color: white;"|MBH_300_QA3_MA | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_QA3_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 50 dagen om 09:10 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 50 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T - 11 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 947: | Regel 960: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 960: | Regel 973: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"| | |style="background-color: white;"|2 maal per dag 50 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
| Regel 973: | Regel 986: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_QA3_MVE | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 993: | Regel 999: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA3_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Medicatieverstrekkings datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 50 dagen om 09:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.018: | Regel 1.010: | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekte hoeveelheid | |||
|style="background-color: white;"|4000 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Relatie verstrekkingsverzoek | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA3_VV | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_QA3_MGB | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.066: | Regel 1.037: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatiegebruik datum tijd | |colspan="4"|Medicatiegebruik datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 9 dagen om 07:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruik indicator | |colspan="4"|Gebruik indicator | ||
| Regel 1.078: | Regel 1.049: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 50 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 11 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 1.093: | Regel 1.064: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
| Regel 1.110: | Regel 1.074: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.120: | Regel 1.087: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 1.126: | Regel 1.093: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"| | |style="background-color: white;"|2 maal per dag 50 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
| Regel 1.133: | Regel 1.100: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |}<section end=MBH_MBH_300_QA3 /><section begin=MBH_MBH_300_QA4 /> | ||
====Medicamenteuze behandeling MBH_300_QA4 ==== | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_QA4_MA | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.146: | Regel 1.122: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Medicatieafspraak datum tijd | ||
|style="background-color: white;"|T om 08: | |style="background-color: white;"|T - 10 dagen om 08:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T + 19 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 1.174: | Regel 1.144: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.193: | Regel 1.156: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_QA4_VV | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.221: | Regel 1.175: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA4_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Verstrekkingsverzoek datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 10 dagen om 08:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |||
|colspan="5"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Te verstrekken hoeveelheid | |||
|style="background-color: white;"|30 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Beoogd verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Relatie medicatieafspraak | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA4_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_QA4_TA | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.274: | Regel 1.217: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Toedieningsafspraak datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 10 dagen om 09:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T + 19 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.314: | Regel 1.254: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 1.327: | Regel 1.267: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_QA4_MVE | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.340: | Regel 1.280: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA4_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieverstrekkings datum tijd | |||
|style="background-color: white;"|T - 10 dagen om 09:12 uur | |||
|colspan=" | |||
|style="background-color: white;"|T - | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 1.362: | Regel 1.291: | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekte hoeveelheid | |||
|style="background-color: white;"|30 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="4"|Relatie verstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_QA4_VV | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_QA4_MGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"| | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| Regel 1.403: | Regel 1.318: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 2 dagen om 08:12 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Volgens afspraak indicator | ||
|style="background-color: white;"| | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T + 19 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Informant | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Informant is patient | ||
|style="background-color: white;"| | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.443: | Regel 1.372: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 1.456: | Regel 1.385: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|}<section end= | |}<section end=MBH_MBH_300_QA4 /><section begin=MBH_MBH_300_QA5 /> | ||
====Medicamenteuze behandeling | ====Medicamenteuze behandeling MBH_300_QA5 ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_QA5_MA | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.478: | Regel 1.400: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 50 dagen om 08:15 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 50 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Gebruiksduur | ||
|style="background-color: white;"| | |style="background-color: white;"|7 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 1.499: | Regel 1.421: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.512: | Regel 1.434: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"| | |style="background-color: white;"|4 maal per dag 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_QA5_VV | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA5_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Verstrekkingsverzoek datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 50 dagen om 08:15 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="5"|Auteur | ||
|style="background-color: #E3E3E3;;"| | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"| | |style="background-color: white;"|56 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|T | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Beoogd verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie medicatieafspraak | |||
|style="background-color: white;"|MBH_300_QA5_MA | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_QA5_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 50 dagen om 09:15 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 50 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|7 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 1.555: | Regel 1.518: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.568: | Regel 1.531: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"| | |style="background-color: white;"|4 maal per dag 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
| Regel 1.581: | Regel 1.544: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_QA5_MVE | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.594: | Regel 1.557: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA5_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Medicatieverstrekkings datum tijd | ||
|style="background-color: white;"|T om | |style="background-color: white;"|T - 50 dagen om 09:15 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Volgens afspraak indicator | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Ja | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekte hoeveelheid | |||
|style="background-color: white;"|56 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie verstrekkingsverzoek | |||
|style="background-color: white;"|MBH_300_QA5_VV | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_QA5_MGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_QA5_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 43 dagen om 08:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 50 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Gebruiksduur | ||
|style="background-color: white;"| | |style="background-color: white;"|7 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 1.621: | Regel 1.622: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Informant | |colspan="5"|Informant | ||
| Regel 1.635: | Regel 1.636: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.648: | Regel 1.652: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 1.654: | Regel 1.658: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"| | |style="background-color: white;"|4 maal per dag 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie | |colspan="5"|Relatie toedieningsafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |}<section end=MBH_MBH_300_QA5 /><section begin=MBH_MBH_300_QA6 /> | ||
====Medicamenteuze behandeling MBH_300_QA6 ==== | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_QA6_MA | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.674: | Regel 1.680: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Medicatieafspraak datum tijd | ||
|style="background-color: white;"|T om 18 | |style="background-color: white;"|T - 5 dagen om 08:18 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 5 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T + 1 dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 1.701: | Regel 1.701: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.721: | Regel 1.714: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"| | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_QA6_VV | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.749: | Regel 1.733: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA6_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Verstrekkingsverzoek datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 5 dagen om 08:18 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="5"|Auteur | ||
|style="background-color: #E3E3E3;;"| | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"| | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Beoogd verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Relatie medicatieafspraak | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA6_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_QA6_TA | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.802: | Regel 1.775: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA6_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 5 dagen om 09:18 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 5 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Einddatum | ||
|style="background-color: white;"|1 | |style="background-color: white;"|T + 1 dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 1.826: | Regel 1.799: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.839: | Regel 1.812: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| Regel 1.852: | Regel 1.825: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_QA6_MVE | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.867: | Regel 1.838: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA6_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Medicatieverstrekkings datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 5 dagen om 09:18 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="5"|Verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekte hoeveelheid | |||
|style="background-color: white;"|21 stuks | |||
|colspan=" | |||
|style="background-color: white;"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Relatie verstrekkingsverzoek | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA6_VV | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_QA6_MGB | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.917: | Regel 1.876: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA6_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 2 dagen om 08:59:59 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Volgens afspraak indicator | ||
|style="background-color: white;"| | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T - 5 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T + | |style="background-color: white;"|T + 1 dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 1.941: | Regel 1.903: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="3"|Informant is patient | ||
|style="background-color: white;"| | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.957: | Regel 1.930: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"| | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
| Regel 1.970: | Regel 1.943: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |}<section end=MBH_MBH_300_QA6 /><section begin=MBH_MBH_300_QA7 /> | ||
====Medicamenteuze behandeling MBH_300_QA7 ==== | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_300_QA7_WDS | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.983: | Regel 1.958: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA7_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Wisselend doseerschema datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 30 dagen om 10:11 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen, gedurende 2 weken'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T - 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|2 weken | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T | |style="background-color: white;"|Vanaf T - 30 dagen, gedurende 2 weken, eerst gedurende 4 dagen 1 maal per dag om 18:00 3 stuks, dan gedurende 6 dagen 1 maal per dag om 18:00 2 stuks, dan gedurende 4 dagen 1 maal per dag om 18:00 3 stuks, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 1 | |||
|style="background-color: white;"|eerst gedurende 4 dagen 1 maal per dag om 18:00 3 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 2 | |||
|style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag om 18:00 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 3 | |||
|style="background-color: white;"|dan gedurende 4 dagen 1 maal per dag om 18:00 3 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Toelichting | ||
|style="background-color: white;"|2 | |style="background-color: white;"|gemeten INR waarde: 2,3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
| Regel 2.030: | Regel 2.014: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA7_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA7 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |}<section end=MBH_MBH_300_QA7 /><section begin=MBH_MBH_300_QA8 /> | ||
====Medicamenteuze behandeling MBH_300_QA8 ==== | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_300_QA8_WDS | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.043: | Regel 2.029: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA8_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Wisselend doseerschema datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 40 dagen om 11:33 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T | |style="background-color: #E3E3E3;;"|''Vanaf T - 40 dagen, gedurende 1 week'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T - 40 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Gebruiksduur | ||
|style="background-color: white;"| | |style="background-color: white;"|1 week | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T | |style="background-color: white;"|Vanaf T - 40 dagen, gedurende 1 week, cyclus van 3 dagen: steeds eerst gedurende 2 dagen 1 maal per dag om 18:00 3 stuks, dan gedurende 1 dag 1 maal per dag om 18:00 2 stuks, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 1 | |||
|style="background-color: white;"|eerst gedurende 2 dagen 1 maal per dag om 18:00 3 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie 2 | ||
|style="background-color: white;"| | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag om 18:00 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="3"|Herhaalperiode cyclisch schema | ||
|style="background-color: white;"|3 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Toelichting | ||
|style="background-color: white;"| | |style="background-color: white;"|gemeten INR waarde: 2,8 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie | |colspan="5"|Relatie medicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA8_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA8 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|}<section end= | |}<section end=MBH_MBH_300_QA8 /><section begin=MBH_MBH_300_QA9 /> | ||
====Medicamenteuze behandeling | ====Medicamenteuze behandeling MBH_300_QA9 ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_300_QA9_WDS | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.121: | Regel 2.100: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA9_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Wisselend doseerschema datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 15 dagen om 14:44 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T | |style="background-color: #E3E3E3;;"|''Vanaf T - 15 dagen, gedurende 10 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T - 15 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|10 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Wisselend doseerschema stop type | ||
|style="background-color: white;"| | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|FENPRCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|FENPRCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T | |style="background-color: white;"|Vanaf T - 15 dagen, gedurende 10 dagen, eerst gedurende 8 dagen 1 maal per dag 1 stuk, dan gedurende 2 dagen 1 maal per dag 0 stuks, Oraal, | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 1 | |||
|style="background-color: white;"|eerst gedurende 8 dagen 1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 2 | |||
|style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 0 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toelichting | |||
|style="background-color: white;"|gemeten INR waarde: 2,1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Identificatie | ||
|style="background-color: white;"|1 | |style="background-color: white;"|MBH_300_QA9_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA9 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |}<section end=MBH_MBH_300_QA9 /><section begin=MBH_MBH_300_QA10 /> | ||
====Medicamenteuze behandeling MBH_300_QA10 ==== | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_300_QA10_WDS | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.174: | Regel 2.171: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA10_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Wisselend doseerschema datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 5 dagen om 13:55 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, gedurende 4 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T - 5 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Gebruiksduur | ||
|style="background-color: white;"| | |style="background-color: white;"|4 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|FENPRCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|FENPRCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 2.211: | Regel 2.205: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T | |style="background-color: white;"|Vanaf T - 5 dagen, gedurende 4 dagen, gedurende 4 dagen 1 maal per dag om 18:00 1 stuk, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|gedurende 4 dagen 1 maal per dag om 18:00 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toelichting | |||
|style="background-color: white;"|gemeten INR waarde: 2,5 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
| Regel 2.224: | Regel 2.221: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA10_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA10 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|}<section end= | |}<section end=MBH_MBH_300_QA10 /><section begin=MBH_MBH_300_QA11 /> | ||
====Medicamenteuze behandeling | ====Medicamenteuze behandeling MBH_300_QA11 ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_300_QA11_WDS | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.239: | Regel 2.236: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA11_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Wisselend doseerschema datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 60 dagen om 10:44 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 8 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Gebruiksduur | ||
|style="background-color: white;"| | |style="background-color: white;"|8 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 60 dagen, gedurende 8 dagen, eerst gedurende 5 dagen 1 maal per dag 4 stuks, dan gedurende 3 dagen 1 maal per dag 3 stuks, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 1 | |||
|style="background-color: white;"|eerst gedurende 5 dagen 1 maal per dag 4 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 2 | |||
|style="background-color: white;"|dan gedurende 3 dagen 1 maal per dag 3 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toelichting | |||
|style="background-color: white;"|gemeten INR waarde: 2,2 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Identificatie | ||
|style="background-color: white;"|1 | |style="background-color: white;"|MBH_300_QA11_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA11 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |}<section end=MBH_MBH_300_QA11 /><section begin=MBH_MBH_300_QA12 /> | ||
====Medicamenteuze behandeling MBH_300_QA12 ==== | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_300_QA12_WDS | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.292: | Regel 2.304: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA12_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Wisselend doseerschema datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 74 dagen om 09:11 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 74 dagen, tot en met T - 61 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 74 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 61 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 74 dagen, tot en met T - 61 dagen, cyclus van 7 dagen: steeds eerst gedurende 2 dagen 1 maal per dag 5 stuks, dan gedurende 5 dagen 1 maal per dag 3 stuks, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 1 | |||
|style="background-color: white;"|eerst gedurende 2 dagen 1 maal per dag 5 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 2 | |||
|style="background-color: white;"|dan gedurende 5 dagen 1 maal per dag 3 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Herhaalperiode cyclisch schema | |||
|style="background-color: white;"|7 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Toelichting | ||
|style="background-color: white;"| | |style="background-color: white;"|gemeten INR waarde: 2,7 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
| Regel 2.345: | Regel 2.360: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA12_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_QA12 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |}<section end=MBH_MBH_300_QA12 /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Zorgverlener identificatienummer | ||
|style="background-color: white;"| | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="3"|Naamgegevens | ||
|style="background-color: white;"|Peter van Pulver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Specialisme | ||
|style="background-color: white;"| | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Tanja_de_Bakker" title="Intern ID = Tanja_de_Bakker">Zorgverlener Tanja_de_Bakker</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Zorgverlener identificatienummer | ||
|style="background-color: white;"| | |style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgegevens | |||
|style="background-color: white;"|Tanja de Bakker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Specialisme | |||
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Trombosedienst_Ons_Dorp|Zorgaanbieder: Trombosedienst_Ons_Dorp]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder identificatienummer | ||
|style="background-color: white;"| | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder identificatienummer | ||
|style="background-color: white;"| | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Organisatie naam | ||
|style="background-color: white;"| | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|<span id="Trombosedienst_Ons_Dorp" title="Intern ID = Trombosedienst_Ons_Dorp">Zorgaanbieder Trombosedienst_Ons_Dorp</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="5"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|11112222 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="3"|Organisatie naam | ||
|style="background-color: white;"|Trombosedienst Ons Dorp | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Afdeling specialisme | ||
|style="background-color: white;"| | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Adresgegevens | ||
|style="background-color: white;"| | |style="background-color: white;"|: Kerkstraat 28 d 1332GH Ons Dorp | ||
|} | |}<section end=ALLMBHS_XXX_Blik /> | ||
==Patiënt R. van XXX_Sonnenberg== | |||
<section begin=XXX_Sonnenberg /> | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Naamgegevens | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="7"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Initialen | ||
|style="background-color: white;"| | |style="background-color: white;"|R. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Naamgebruik | ||
|style="background-color: white;"| | |style="background-color: white;"|1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="2"|Voorvoegsels | ||
|style="background-color: white;"| | |style="background-color: white;"|van | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="2"|Achternaam | ||
|style="background-color: white;"| | |style="background-color: white;"|XXX_Sonnenberg | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Identificatienummer | ||
|style="background-color: white;"| | |style="background-color: white;"|999901084 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="4"|Geboortedatum | ||
|style="background-color: white;"|1985-11-20 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Geslacht | ||
|style="background-color: white;"| | |style="background-color: white;"|2 | ||
|}<section end=XXX_Sonnenberg /><section begin=ALLMBHS_XXX_Sonnenberg /><section end=ALLMBHS_XXX_Sonnenberg /> | |||
==Patiënt C. XXX_Brugge== | |||
<section begin=XXX_Brugge /> | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Naamgegevens | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Initialen | ||
|style="background-color: white;"| | |style="background-color: white;"|C. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Naamgebruik | ||
|style="background-color: white;"| | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="2"|Achternaam | ||
|style="background-color: white;"| | |style="background-color: white;"|XXX_Brugge | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Identificatienummer | ||
|style="background-color: white;"| | |style="background-color: white;"|999900419 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Geboortedatum | ||
|style="background-color: white;"| | |style="background-color: white;"|16 okt 1963 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |||
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
|colspan=" | |}<section end=XXX_Brugge /><section begin=ALLMBHS_XXX_Brugge /><section begin=MBH_MBH_300_start_eind /> | ||
====Medicamenteuze behandeling MBH_300_start_eind ==== | |||
|style="background-color: white;"| | |||
|}<section end= | |||
====Medicamenteuze behandeling | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_start_eind_MA | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.496: | Regel 2.534: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 10 dagen om 11:20 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 5 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 2.514: | Regel 2.555: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 2.527: | Regel 2.568: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"| | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_start_eind_VV | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Verstrekkingsverzoek datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 10 dagen om 11:20 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |||
|colspan="5"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"| | |style="background-color: white;"|5 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Beoogd verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |||
|style="background-color: white;"|MBH_300_start_eind_MA | |||
|colspan=" | |||
|style="background-color: white;"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_start_eind_TA | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.606: | Regel 2.628: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Toedieningsafspraak datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 10 dagen om 12:20 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T - 5 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 2.643: | Regel 2.665: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 maal per dag 1 stuk, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"| | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
| Regel 2.656: | Regel 2.678: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_start_eind_MVE | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.669: | Regel 2.691: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_eind_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Medicatieverstrekkings datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 10 dagen om 12:20 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 2.688: | Regel 2.702: | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekte hoeveelheid | |||
|style="background-color: white;"|5 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie verstrekkingsverzoek | |||
|style="background-color: white;"|MBH_300_start_eind_VV | |||
|colspan=" | |||
|style="background-color: white;"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_start_eind_MGB | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.729: | Regel 2.729: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_eind_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 4 dagen om 10:59:59 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Gebruik indicator | ||
|style="background-color: white;"| | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 10 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 5 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Informant | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 2.766: | Regel 2.786: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"| | |style="background-color: white;"|1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie toedieningsafspraak | |colspan="5"|Relatie toedieningsafspraak | ||
| Regel 2.786: | Regel 2.799: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_start_eind_MGB_patient | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.799: | Regel 2.812: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_eind_MGB_patient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Medicatiegebruik datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 4 dagen om 10:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T - 5 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Auteur is patient | ||
|style="background-color: white;"| | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 2.839: | Regel 2.862: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"| | |style="background-color: white;"|1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie toedieningsafspraak | |colspan="5"|Relatie toedieningsafspraak | ||
| Regel 2.859: | Regel 2.875: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|}<section end= | |}<section end=MBH_MBH_300_start_eind /><section begin=MBH_MBH_300_start_duur /> | ||
====Medicamenteuze behandeling | ====Medicamenteuze behandeling MBH_300_start_duur ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_start_duur_MA | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.874: | Regel 2.890: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Medicatieafspraak datum tijd | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 20 dagen om 11:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - | |style="background-color: white;"|T - 20 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Gebruiksduur | ||
|style="background-color: white;"| | |style="background-color: white;"|3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 2.912: | Regel 2.924: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|Vanaf T - | |style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 2.921: | Regel 2.933: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_start_duur_VV | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_start_duur_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekkingsverzoek datum tijd | |||
|style="background-color: white;"|T om 11:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="4"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"|21 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="5"|Beoogd verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="4"|Relatie medicatieafspraak | ||
|style="background-color: white;"|MBH_300_start_duur_MA | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_start_duur_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_duur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Toedieningsafspraak datum tijd | ||
|style="background-color: white;"| | |style="background-color: white;"|T - 20 dagen om 12:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Gebruiksperiode | ||
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruiksduur | ||
|style="background-color: white;"| | |style="background-color: white;"|3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="4"|Geneesmiddel - generiekere code | ||
| | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Omschrijving | ||
|style="background-color: white;"| | |style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"| | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"| | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Relatie medicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| | |} | ||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_start_duur_MVE | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="4"|Identificatie | ||
|style="background-color: white;"|MBH_300_start_duur_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Medicatieverstrekkings datum tijd | ||
|style="background-color: white;"| | |style="background-color: white;"|T - 20 dagen om 12:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="4"|Verstrekte hoeveelheid | ||
|style="background-color: white;"|21 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Relatie verstrekkingsverzoek | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_duur_VV | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_start_duur_MGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_start_duur_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 1 dag om 12:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|3 weken | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="4"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
|}<section end= | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_start_duur /><section begin=MBH_MBH_300_chronisch /> | |||
====Medicamenteuze behandeling MBH_300_chronisch ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_chronisch_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
[[ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 30 dagen om 11:32 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 30 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_chronisch_VV | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_chronisch_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekkingsverzoek datum tijd | |||
|style="background-color: white;"|T - 30 dagen om 11:32 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Te verstrekken hoeveelheid | |||
|style="background-color: white;"|21 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Beoogd verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie medicatieafspraak | |||
|style="background-color: white;"|MBH_300_chronisch_MA | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_chronisch_VV_extraVVbestaandeMA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_chronisch_VV_extraVVbestaandeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekkingsverzoek datum tijd | |||
|style="background-color: white;"|T - 10 dagen om 11:35 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Te verstrekken hoeveelheid | |||
|style="background-color: white;"|90 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Beoogd verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie medicatieafspraak | |||
|style="background-color: white;"|MBH_300_chronisch_MA | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_chronisch_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 30 dagen om 12:32 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 30 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_chronisch_MVE | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_chronisch_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieverstrekkings datum tijd | |||
|style="background-color: white;"|T - 30 dagen om 12:32 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekte hoeveelheid | |||
|style="background-color: white;"|21 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie verstrekkingsverzoek | |||
|style="background-color: white;"|MBH_300_chronisch_VV | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_chronisch_MVE_extraMVEbestaandeTA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_chronisch_MVE_extraMVEbestaandeTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieverstrekkings datum tijd | |||
|style="background-color: white;"|T - 10 dagen om 12:35 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekte hoeveelheid | |||
|style="background-color: white;"|90 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie verstrekkingsverzoek | |||
|style="background-color: white;"|MBH_300_chronisch_VV_extraVVbestaandeMA | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatiegebruik MBH_300_chronisch_MGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="5" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Identificatie | |||
|style="background-color: white;"|MBH_300_chronisch_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 20 dagen om 11:43:12 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Ingangsdatum | |||
|style="background-color: white;"|T - 30 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur is zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Itis|Zorgaanbieder: Huisartsenpraktijk_Itis]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_chronisch_MGB_patient | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_chronisch_MGB_patient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 20 dagen om 11:43:12 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 30 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Auteur is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatiegebruik MBH_300_chronisch_MGB_informant_Zorgverlener | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="5" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Identificatie | |||
|style="background-color: white;"|MBH_300_chronisch_MGB_informant_Zorgverlener (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 10 dagen om 11:43:12 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur is zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Omschrijving | |||
|style="background-color: white;"|oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_chronisch /><section begin=MBH_MBH_300_start_duur2 /> | |||
====Medicamenteuze behandeling MBH_300_start_duur2 ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_start_duur2_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 60 dagen om 11:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 60 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|28 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_start_duur2_VV | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_start_duur2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekkingsverzoek datum tijd | |||
|style="background-color: white;"|T - 60 dagen om 11:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Te verstrekken hoeveelheid | |||
|style="background-color: white;"|28 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Beoogd verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie medicatieafspraak | |||
|style="background-color: white;"|MBH_300_start_duur2_MA | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_start_duur2_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_start_duur2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 60 dagen om 12:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 60 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|28 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_start_duur2_MVE | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_start_duur2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieverstrekkings datum tijd | |||
|style="background-color: white;"|T - 60 dagen om 12:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekte hoeveelheid | |||
|style="background-color: white;"|28 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie verstrekkingsverzoek | |||
|style="background-color: white;"|MBH_300_start_duur2_VV | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_start_duur2_MGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_start_duur2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 55 dagen om 15:21:33 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 60 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|28 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_start_duur2 /><section begin=MBH_MBH_300_dosis_stuks /> | |||
====Medicamenteuze behandeling MBH_300_dosis_stuks ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_dosis_stuks_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 130 dagen om 11:35 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 130 dagen, tot en met T - 101 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 130 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 101 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 1 dosis | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_dosis_stuks_VV | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_dosis_stuks_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekkingsverzoek datum tijd | |||
|style="background-color: white;"|T - 130 dagen om 11:35 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Te verstrekken hoeveelheid | |||
|style="background-color: white;"|1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Beoogd verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie medicatieafspraak | |||
|style="background-color: white;"|MBH_300_dosis_stuks_MA | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_dosis_stuks_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_dosis_stuks_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 130 dagen om 12:35 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 130 dagen, tot en met T - 101 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 130 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 101 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 1 dosis | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_dosis_stuks_MVE | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_dosis_stuks_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieverstrekkings datum tijd | |||
|style="background-color: white;"|T - 130 dagen om 12:35 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekte hoeveelheid | |||
|style="background-color: white;"|1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie verstrekkingsverzoek | |||
|style="background-color: white;"|MBH_300_dosis_stuks_VV | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_dosis_stuks_MGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_dosis_stuks_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 100 dagen om 07:59:59 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|2 maal per dag 1 dosis, inhalatie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 1 dosis | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_dosis_stuks /><section begin=MBH_MBH_300_nieuweMBHobvTA /> | |||
====Medicamenteuze behandeling MBH_300_nieuweMBHobvTA ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_nieuweMBHobvTA_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweMBHobvTA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 10 dagen om 10:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 10 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 5 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PARACETAMOL APOTEX TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '67903' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '2194' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, Zo nodig 3 maal per dag 2 stuks, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|Zo nodig 3 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_nieuweMBHobvTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_nieuweMBHobvTA_MVE | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweMBHobvTA_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieverstrekkings datum tijd | |||
|style="background-color: white;"|T - 10 dagen om 10:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekte hoeveelheid | |||
|style="background-color: white;"|30 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PARACETAMOL APOTEX TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '67903' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '2194' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_nieuweMBHobvTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_nieuweMBHobvTA_MGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweMBHobvTA_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 3 dagen om 16:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen om 10:00 uur, tot en met T - 3 dagen om 16:00 uur'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 10 dagen om 10:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 3 dagen om 16:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Auteur is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PARACETAMOL APOTEX TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '67903' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '2194' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 10 dagen om 10:00 uur, tot en met T - 3 dagen om 16:00 uur, 3 maal per dag 2 stuks, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|3 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweMBHobvTA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_nieuweMBHobvTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_nieuweMBHobvTA /><section begin=MBH_MBH_300_WDS_start_duur /> | |||
====Medicamenteuze behandeling MBH_300_WDS_start_duur ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_300_WDS_start_duur_WDS | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_WDS_start_duur_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Wisselend doseerschema datum tijd | |||
|style="background-color: white;"|T - 10 dagen om 11:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, gedurende 2 weken'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 10 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|2 weken | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="7"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 10 dagen, gedurende 2 weken, eerst gedurende 1 dag 1 maal per dag 2 stuks, dan gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 1 stuk, dan gedurende 6 dagen 1 maal per dag 3 stuks, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 1 | |||
|style="background-color: white;"|eerst gedurende 1 dag 1 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 2 | |||
|style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 3 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 3 | |||
|style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 4 | |||
|style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 3 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_WDS_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_WDS_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_WDS_start_duur /><section begin=MBH_ MBH_300_WDS_start_duur2 /> | |||
====Medicamenteuze behandeling MBH_300_WDS_start_duur2 ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_300_WDS_start_duur2_WDS | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_WDS_start_duur2_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Wisselend doseerschema datum tijd | |||
|style="background-color: white;"|T - 15 dagen om 11:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 15 dagen, gedurende 13 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 15 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|13 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 15 dagen, gedurende 13 dagen, gedurende 13 dagen 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|gedurende 13 dagen 1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_WDS_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_WDS_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_ MBH_300_WDS_start_duur2 /> | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="7"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener identificatienummer | |||
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgegevens | |||
|style="background-color: white;"|Peter van Pulver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Specialisme | |||
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Marcha_van_Partners" title="Intern ID = Marcha_van_Partners">Zorgverlener Marcha_van_Partners</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="7"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener identificatienummer | |||
|style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgegevens | |||
|style="background-color: white;"|Marcha van Partners | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Specialisme | |||
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Itis|Zorgaanbieder: Huisartsenpraktijk_Itis]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Tanja_de_Bakker" title="Intern ID = Tanja_de_Bakker">Zorgverlener Tanja_de_Bakker</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="7"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener identificatienummer | |||
|style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgegevens | |||
|style="background-color: white;"|Tanja de Bakker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Specialisme | |||
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Trombosedienst_Ons_Dorp|Zorgaanbieder: Trombosedienst_Ons_Dorp]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Apotheek De Gulle Gaper | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Huisartsenpraktijk_Itis" title="Intern ID = Huisartsenpraktijk_Itis">Zorgaanbieder Huisartsenpraktijk_Itis</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|00005111 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Huisartsenpraktijk Itis | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Trombosedienst_Ons_Dorp" title="Intern ID = Trombosedienst_Ons_Dorp">Zorgaanbieder Trombosedienst_Ons_Dorp</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="5"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|11112222 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Trombosedienst Ons Dorp | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Afdeling specialisme | |||
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|: Kerkstraat 28 d 1332GH Ons Dorp | |||
|}<section end=ALLMBHS_XXX_Brugge /> | |||
==Patiënt M. XXX_Niesing== | |||
<section begin=XXX_Niesing /> | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Naamgegevens | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="6"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Initialen | |||
|style="background-color: white;"|M. | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgebruik | |||
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geslachtsnaam | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Achternaam | |||
|style="background-color: white;"|XXX_Niesing | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatienummer | |||
|style="background-color: white;"|999900845 [BSN] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geboortedatum | |||
|style="background-color: white;"|29 okt 1985 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geslacht | |||
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
|}<section end=XXX_Niesing /><section begin=ALLMBHS_XXX_Niesing /><section begin=MBH_MBH_300_HPKvoorschrijven /> | |||
====Medicamenteuze behandeling MBH_300_HPKvoorschrijven ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_HPKvoorschrijven_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 170 dagen om 13:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 170 dagen, tot en met T - 21 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 170 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 21 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_HPKvoorschrijven_VV | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekkingsverzoek datum tijd | |||
|style="background-color: white;"|T - 170 dagen om 13:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Te verstrekken hoeveelheid | |||
|style="background-color: white;"|150 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Beoogd verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie medicatieafspraak | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven_MA | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_HPKvoorschrijven_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 170 dagen om 14:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 170 dagen, tot en met T - 21 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 170 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 21 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_HPKvoorschrijven_MVE | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieverstrekkings datum tijd | |||
|style="background-color: white;"|T - 170 dagen om 14:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekte hoeveelheid | |||
|style="background-color: white;"|150 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie verstrekkingsverzoek | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven_VV | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_HPKvoorschrijven_MGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T om 22:08 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_HPKvoorschrijven_MGB_patient | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven_MGB_patient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T om 22:08 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Auteur is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_HPKvoorschrijven /><section begin=MBH_MBH_300_ZINRvoorschrijven /> | |||
====Medicamenteuze behandeling MBH_300_ZINRvoorschrijven ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_ZINRvoorschrijven_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T om 13:05 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 150 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_ZINRvoorschrijven_VV | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekkingsverzoek datum tijd | |||
|style="background-color: white;"|T om 13:05 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Te verstrekken hoeveelheid | |||
|style="background-color: white;"|150 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Beoogd verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie medicatieafspraak | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_ZINRvoorschrijven_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T om 14:05 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 150 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_ZINRvoorschrijven_MVE | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieverstrekkings datum tijd | |||
|style="background-color: white;"|T om 14:05 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekte hoeveelheid | |||
|style="background-color: white;"|150 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie verstrekkingsverzoek | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_VV | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_ZINRvoorschrijven_MGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T om 22:08 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_ZINRvoorschrijven_MGB_patient | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MGB_patient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T om 22:08 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Auteur is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_ZINRvoorschrijven /><section begin=MBH_MBH_300_WDSmetHPK /> | |||
====Medicamenteuze behandeling MBH_300_WDSmetHPK ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_300_WDSmetHPK_WDS | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_WDSmetHPK_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Wisselend doseerschema datum tijd | |||
|style="background-color: white;"|T - 3 dagen om 16:25 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, gedurende 7 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 3 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|7 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|MARCOUMAR TABLET 3MG (code = '52477' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="7"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 3 dagen, gedurende 7 dagen, eerst gedurende 3 dagen 1 maal per dag 0.5 stuk, dan gedurende 1 dag 1 maal per dag 0 stuks, dan gedurende 2 dagen 1 maal per dag 0.5 stuk, dan gedurende 1 dag 1 maal per dag 0 stuks, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 1 | |||
|style="background-color: white;"|eerst gedurende 3 dagen 1 maal per dag 0.5 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 2 | |||
|style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 0 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 3 | |||
|style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 0.5 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 4 | |||
|style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 0 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_WDSmetHPK_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_WDSmetHPK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_WDSmetHPK /> | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="7"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener identificatienummer | |||
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgegevens | |||
|style="background-color: white;"|Peter van Pulver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Specialisme | |||
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Apotheek De Gulle Gaper | |||
|}<section end=ALLMBHS_XXX_Niesing /> | |||
==Patiënt J. XXX_Bree== | |||
<section begin=XXX_Bree /> | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Naamgegevens | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="6"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Initialen | |||
|style="background-color: white;"|J. | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgebruik | |||
|style="background-color: white;"|1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geslachtsnaam | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Achternaam | |||
|style="background-color: white;"|XXX_Bree | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatienummer | |||
|style="background-color: white;"|999901588 [BSN] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geboortedatum | |||
|style="background-color: white;"|2010-07-01 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geslacht | |||
|style="background-color: white;"|2 | |||
|}<section end=XXX_Bree /><section begin=ALLMBHS_XXX_Bree /><section end=ALLMBHS_XXX_Bree /> | |||
==Patiënt M. XXX_Pherai== | |||
<section begin=XXX_Pherai /> | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Naamgegevens | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="6"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Initialen | |||
|style="background-color: white;"|M. | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgebruik | |||
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geslachtsnaam | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Achternaam | |||
|style="background-color: white;"|XXX_Pherai | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatienummer | |||
|style="background-color: white;"|999900870 [BSN] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geboortedatum | |||
|style="background-color: white;"|1 nov 1985 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geslacht | |||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
|}<section end=XXX_Pherai /><section begin=ALLMBHS_XXX_Pherai /><section begin=MBH_MBH_300_wdsmtd1 /> | |||
====Medicamenteuze behandeling MBH_300_wdsmtd1 ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_wdsmtd1_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 20 dagen om 08:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 20 dagen, Volgens schema trombosedienst, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Aanvullende instructie | |||
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_300_wdsmtd1_WDS_opstartschema | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Wisselend doseerschema datum tijd | |||
|style="background-color: white;"|T - 20 dagen om 08:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 15 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 15 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="5"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 15 dagen, eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks, dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 1 | |||
|style="background-color: white;"|eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 2 | |||
|style="background-color: white;"|dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_300_wdsmtd1_WDS_trombosedienst | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Wisselend doseerschema datum tijd | |||
|style="background-color: white;"|T - 15 dagen om 14:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T - 5 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 14 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 5 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="7"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T - 5 dagen, cyclus van 5 dagen: steeds eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 1 | |||
|style="background-color: white;"|eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 2 | |||
|style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 3 | |||
|style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Herhaalperiode cyclisch schema | |||
|style="background-color: white;"|5 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie wisselend doseerschema | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_300_wdsmtd1_WDS_technischestop | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_technischestop (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Wisselend doseerschema datum tijd | |||
|style="background-color: white;"|T - 7 dagen om 10:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T - 7 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 14 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 7 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Wisselend doseerschema stop type | |||
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="7"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T - 7 dagen, cyclus van 5 dagen: steeds eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 1 | |||
|style="background-color: white;"|eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 2 | |||
|style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 3 | |||
|style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Herhaalperiode cyclisch schema | |||
|style="background-color: white;"|5 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie wisselend doseerschema | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_300_wdsmtd1_WDS_verhoging | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Wisselend doseerschema datum tijd | |||
|style="background-color: white;"|T - 7 dagen om 10:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 6 dagen, tot en met T + 3 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 6 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 3 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Reden wijzigen of staken | |||
|style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="6"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 6 dagen, tot en met T + 3 dagen, cyclus van 5 dagen: steeds eerst gedurende 3 dagen 1 maal per dag om 19:00 2 stuks, dan gedurende 2 dagen 1 maal per dag om 19:00 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 1 | |||
|style="background-color: white;"|eerst gedurende 3 dagen 1 maal per dag om 19:00 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie 2 | |||
|style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag om 19:00 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Herhaalperiode cyclisch schema | |||
|style="background-color: white;"|5 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toelichting | |||
|style="background-color: white;"|Dosering aangepast i.v.m. te lage INR waarde. | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie wisselend doseerschema | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_wdsmtd1_VV | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekkingsverzoek datum tijd | |||
|style="background-color: white;"|T - 20 dagen om 08:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Te verstrekken hoeveelheid | |||
|style="background-color: white;"|60 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Beoogd verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie medicatieafspraak | |||
|style="background-color: white;"|MBH_300_wdsmtd1_MA | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_wdsmtd1_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 20 dagen om 09:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 20 dagen, Volgens schema trombosedienst, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Aanvullende instructie | |||
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_wdsmtd1_MVE | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieverstrekkings datum tijd | |||
|style="background-color: white;"|T - 20 dagen om 09:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekte hoeveelheid | |||
|style="background-color: white;"|60 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Relatie verstrekkingsverzoek | |||
|style="background-color: white;"|MBH_300_wdsmtd1_VV | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatietoediening MBH_300_wdsmtd1_MTD1 | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="5" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Toedienings datum tijd | |||
|style="background-color: white;"|T - 20 dagen om 20:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Afgesproken datum tijd | |||
|style="background-color: white;"|T - 20 dagen om 20:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Toegediende hoeveelheid | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Aantal | |||
|style="background-color: white;"|1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Eenheid | |||
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Afgesproken hoeveelheid | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Aantal | |||
|style="background-color: white;"|2 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Eenheid | |||
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Toedieningsweg | |||
|style="background-color: white;"|ORAAL (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Toediener | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Mantelzorger | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Contactpersoon | |||
|style="background-color: white;"|Zie [[#Toos_de_Bakker|Contactpersoon: Toos_de_Bakker]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Relatie wisselend doseerschema | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_wdsmtd1_MTD2 | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_MTD2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedienings datum tijd | |||
|style="background-color: white;"|T - 19 dagen om 20:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Afgesproken datum tijd | |||
|style="background-color: white;"|T - 19 dagen om 20:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Nee | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Toegediende hoeveelheid | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Aantal | |||
|style="background-color: white;"|1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Eenheid | |||
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Afgesproken hoeveelheid | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Aantal | |||
|style="background-color: white;"|2 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Eenheid | |||
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Toediener | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Thuiszorg_Om_en_Bij|Zorgaanbieder: Thuiszorg_Om_en_Bij]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatietoediening reden van afwijken | |||
|style="background-color: white;"|toediening van medicatie geweigerd (code = '406149000' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie wisselend doseerschema | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_wdsmtd1_MTD3 | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_MTD3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedienings datum tijd | |||
|style="background-color: white;"|T - 17 dagen om 20:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Afgesproken datum tijd | |||
|style="background-color: white;"|T - 17 dagen om 20:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Nee | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Toegediende hoeveelheid | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Aantal | |||
|style="background-color: white;"|1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Eenheid | |||
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Afgesproken hoeveelheid | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Aantal | |||
|style="background-color: white;"|1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Eenheid | |||
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Toediener | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Thuiszorg_Om_en_Bij|Zorgaanbieder: Thuiszorg_Om_en_Bij]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatietoediening reden van afwijken | |||
|style="background-color: white;"|niet in staat om medicatie te gebruiken (code = '408366001' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toelichting | |||
|style="background-color: white;"|Geprobeerd, maar niet gelukt met de tablet | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie wisselend doseerschema | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_wdsmtd1_MTD4 | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_MTD4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedienings datum tijd | |||
|style="background-color: white;"|T - 16 dagen om 20:05 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Afgesproken datum tijd | |||
|style="background-color: white;"|T - 16 dagen om 20:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Nee | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Toegediende hoeveelheid | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Aantal | |||
|style="background-color: white;"|0 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Eenheid | |||
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Afgesproken hoeveelheid | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Aantal | |||
|style="background-color: white;"|1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Eenheid | |||
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Toediener | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Thuiszorg_Om_en_Bij|Zorgaanbieder: Thuiszorg_Om_en_Bij]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatietoediening reden van afwijken | |||
|style="background-color: white;"|zorgafnemer niet beschikbaar om medicatie in ontvangst te nemen (code = '153241000146104' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie wisselend doseerschema | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_wdsmtd1 /> | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Toos_de_Bakker" title="Intern ID = Toos_de_Bakker">Contactpersoon Toos_de_Bakker</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgegevens | |||
|style="background-color: white;"|Toos de Bakker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Rol | |||
|style="background-color: white;"|Mantelzorger (code = '100001' in codeSystem '2.16.840.1.113883.2.4.3.11.60.40.4.23.1') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="7"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener identificatienummer | |||
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgegevens | |||
|style="background-color: white;"|Peter van Pulver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Specialisme | |||
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Tanja_de_Bakker" title="Intern ID = Tanja_de_Bakker">Zorgverlener Tanja_de_Bakker</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="7"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener identificatienummer | |||
|style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgegevens | |||
|style="background-color: white;"|Tanja de Bakker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Specialisme | |||
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Trombosedienst_Ons_Dorp|Zorgaanbieder: Trombosedienst_Ons_Dorp]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Trombosedienst_Ons_Dorp" title="Intern ID = Trombosedienst_Ons_Dorp">Zorgaanbieder Trombosedienst_Ons_Dorp</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="5"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|11112222 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Trombosedienst Ons Dorp | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Afdeling specialisme | |||
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|: Kerkstraat 28 d 1332GH Ons Dorp | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Apotheek De Gulle Gaper | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Thuiszorg_Om_en_Bij" title="Intern ID = Thuiszorg_Om_en_Bij">Zorgaanbieder Thuiszorg_Om_en_Bij</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Thuiszorg Om en Bij | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie type | |||
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '2.16.840.1.113883.2.4.15.1060') | |||
|}<section end=ALLMBHS_XXX_Pherai /> | |||
==Patiënt M. van de XXX_Roelofs== | |||
<section begin=XXX_Roelofs /> | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Naamgegevens | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="7"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Initialen | |||
|style="background-color: white;"|M. | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgebruik | |||
|style="background-color: white;"|1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geslachtsnaam | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Voorvoegsels | |||
|style="background-color: white;"|van de | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Achternaam | |||
|style="background-color: white;"|XXX_Roelofs | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatienummer | |||
|style="background-color: white;"|999900973 [BSN] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geboortedatum | |||
|style="background-color: white;"|1985-11-10 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geslacht | |||
|style="background-color: white;"|2 | |||
|}<section end=XXX_Roelofs /><section begin=ALLMBHS_XXX_Roelofs /><section end=ALLMBHS_XXX_Roelofs /> | |||
==Patiënt C. XXX_Dijk== | |||
<section begin=XXX_Dijk /> | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Naamgegevens | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="6"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Initialen | |||
|style="background-color: white;"|C. | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgebruik | |||
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geslachtsnaam | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Achternaam | |||
|style="background-color: white;"|XXX_Dijk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatienummer | |||
|style="background-color: white;"|999900456 [BSN] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geboortedatum | |||
|style="background-color: white;"|20 okt 1963 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geslacht | |||
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
|}<section end=XXX_Dijk /><section begin=ALLMBHS_XXX_Dijk /><section begin=MBH_MBH_300_gestopt /> | |||
====Medicamenteuze behandeling MBH_300_gestopt ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gestopt_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 4 maanden om 08:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 5 maanden'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 4 maanden | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 5 maanden | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 5 maanden, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gestopt_MA_staken | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 10 dagen om 18:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T - 10 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 4 maanden | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 10 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak stop type | |||
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Reden wijzigen of staken | |||
|style="background-color: white;"|geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gestopt_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 4 maanden om 09:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 5 maanden'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 4 maanden | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 5 maanden | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 5 maanden, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gestopt_TA_staken | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestopt_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 10 dagen om 19:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T - 10 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 4 maanden | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 10 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak stop type | |||
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_gestopt /><section begin=MBH_MBH_300_gewijzigd /> | |||
====Medicamenteuze behandeling MBH_300_gewijzigd ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gewijzigd_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 21 dagen om 08:02 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 21 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gewijzigd_MA_wijziging | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 2 dagen om 08:02 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 2 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Reden wijzigen of staken | |||
|style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 2 dagen, 2 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gewijzigd_MA_techstaken | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 2 dagen om 08:02 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 21 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 3 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak stop type | |||
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 21 dagen om 09:02 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 21 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_TA_wijziging | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 2 dagen om 09:02 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 2 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 2 dagen, 2 maal per dag 2 stuks, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_TA_techstaken | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 2 dagen om 09:02 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 21 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 3 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak stop type | |||
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_gewijzigd /><section begin=MBH_MBH_300_gewijzigddoorander /> | |||
====Medicamenteuze behandeling MBH_300_gewijzigddoorander ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gewijzigddoorander_MA_eigen | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 60 dagen om 08:05 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 14 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 60 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 14 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T + 14 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gewijzigddoorander_MA_wijzigingdoorander | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 3 dagen om 08:10 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, tot en met T + 30 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 3 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 30 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Reden wijzigen of staken | |||
|style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 3 dagen, tot en met T + 30 dagen, 1 maal per dag 2 stuks, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gewijzigddoorander_MA_techstakendoorander | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 3 dagen om 08:10 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 4 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 60 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 4 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak stop type | |||
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T - 4 dagen, 1 maal per dag 1 stuk, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gewijzigddoorander_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 60 dagen om 09:05 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 14 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 60 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 14 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T + 14 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gewijzigddoorander_TA_wijziging | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 3 dagen om 09:10 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, tot en met T + 30 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 3 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 30 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 3 dagen, tot en met T + 30 dagen, 1 maal per dag 2 stuks, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gewijzigddoorander_TA_techstaken | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 3 dagen om 09:10 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 4 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 60 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 4 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak stop type | |||
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T - 4 dagen, 1 maal per dag 1 stuk, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_gewijzigddoorander_MGB_zv | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 3 dagen om 08:08 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 3 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 60 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 3 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_gewijzigddoorander_MGB_pat | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T om 08:08 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, tot en met T - 1 dag'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 3 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 1 dag | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Auteur is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 3 dagen, tot en met T - 1 dag, 1 maal per dag 2 stuks, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_gewijzigddoorander /><section begin=MBH_MBH_300_onderbroken /> | |||
====Medicamenteuze behandeling MBH_300_onderbroken ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_onderbroken_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 153 dagen om 08:06 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T + 20 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 153 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 153 dagen, tot en met T + 20 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_onderbroken_MA_onderbreken | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 100 dagen om 18:12 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T - 100 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 153 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 100 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak stop type | |||
|style="background-color: white;"|onderbroken (code = '385655000' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Reden wijzigen of staken | |||
|style="background-color: white;"|verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 153 dagen, tot en met T - 100 dagen, 1 maal per dag 1 stuk, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_onderbroken_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 153 dagen om 09:06 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T + 20 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 153 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 153 dagen, tot en met T + 20 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_onderbroken_TA_onderbreken | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_onderbroken_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 100 dagen om 19:12 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T - 100 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 153 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 100 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak stop type | |||
|style="background-color: white;"|onderbroken (code = '385655000' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 153 dagen, tot en met T - 100 dagen, 1 maal per dag 1 stuk, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_onderbroken /><section begin=MBH_MBH_300_andermans1 /> | |||
====Medicamenteuze behandeling MBH_300_andermans1 ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_andermans1_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_andermans1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 10 dagen om 18:05 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T + 15 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 9 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 15 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Jan_van_Harten|Zorgverlener: Jan_van_Harten]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 9 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_andermans1_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_andermans1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 10 dagen om 18:45 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T + 15 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 9 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 15 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PANTOPRAZOL TEVA TABLET MSR 20MG (code = '2002914' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 9 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_andermans1_MGB_zv | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_andermans1_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T om 08:08 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 9 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Jan_van_Harten|Zorgverlener: Jan_van_Harten]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Jan_van_Harten|Zorgverlener: Jan_van_Harten]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 9 dagen, tot en met T, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_andermans1_MGB_pat | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_andermans1_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T om 18:08 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 9 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Jan_van_Harten|Zorgverlener: Jan_van_Harten]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Auteur is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 9 dagen, tot en met T, 1 maal per dag 2 stuks, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_andermans1 /><section begin=MBH_MBH_300_andermans2 /> | |||
====Medicamenteuze behandeling MBH_300_andermans2 ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_andermans2_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_andermans2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 159 dagen om 08:15 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 159 dagen, gedurende 1 week'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 159 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|1 week | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Jan_van_Harten|Zorgverlener: Jan_van_Harten]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 159 dagen, gedurende 1 week, 3 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|3 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_andermans2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_andermans2_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_andermans2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 159 dagen om 09:15 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 159 dagen, gedurende 1 week'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 159 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|1 week | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 159 dagen, gedurende 1 week, 3 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|3 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_eigen2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_andermans2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_andermans2 /><section begin=MBH_MBH_300_gebruik /> | |||
====Medicamenteuze behandeling MBH_300_gebruik ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_gebruik_MGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gebruik_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 1 dag om 08:12 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 2 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 10 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 2 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Auteur is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - Product specificatie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Product naam | |||
|style="background-color: white;"|Paracetamol 500mg | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 2 dagen, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gebruik (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_gebruik /><section begin=MBH_MBH_300_geannuleerd /> | |||
====Medicamenteuze behandeling MBH_300_geannuleerd ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_geannuleerd_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_geannuleerd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 2 dagen om 18:15 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 5 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 5 dagen, 2 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_geannuleerd_MA_annuleren | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_geannuleerd_MA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 1 dag om 15:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 5 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 5 dagen om 00:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak stop type | |||
|style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Reden wijzigen of staken | |||
|style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur, 2 maal per dag 1 stuk, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard ') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_geannuleerd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_geannuleerd_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_geannuleerd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 2 dagen om 19:05 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 5 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 5 dagen, 2 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_andermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_geannuleerd_TA_annuleren | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_geannuleerd_TA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 1 dag om 16:45 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 5 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 5 dagen om 00:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak stop type | |||
|style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak reden wijzigen of staken | |||
|style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur, 2 maal per dag 1 stuk, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_geannuleerd_MA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_geannuleerd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_geannuleerd /><section begin=MBH_MBH_300_toekomstig /> | |||
====Medicamenteuze behandeling MBH_300_toekomstig ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_toekomstig_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 1 dag om 08:15 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 15 dagen, tot en met T + 51 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 15 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 51 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 15 dagen, tot en met T + 51 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_toekomstig_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_toekomstig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 1 dag om 09:15 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 15 dagen, tot en met T + 51 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 15 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 51 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DOXYCYCLINE PCH TABLET 100MG (code = '1141317' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 15 dagen, tot en met T + 51 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_toekomstig /><section begin=MBH_MBH_300_gestoptandermans /> | |||
====Medicamenteuze behandeling MBH_300_gestoptandermans ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gestoptandermans_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 20 dagen om 08:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 7 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 7 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 7 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gestoptandermans_MA_staken | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 10 dagen om 18:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 10 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 10 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak stop type | |||
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Reden wijzigen of staken | |||
|style="background-color: white;"|geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gestoptandermans_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 20 dagen om 09:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 7 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 7 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 7 dagen, 1 maal per dag 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gestoptandermans_TA_staken | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestoptandermans_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 10 dagen om 19:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 10 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 10 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak stop type | |||
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_gestoptandermans /><section begin=MBH_MBH_300_gewijzigd_toekomst /> | |||
====Medicamenteuze behandeling MBH_300_gewijzigd_toekomst ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gewijzigd_toekomst_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 11 dagen om 08:20 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 11 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 11 dagen, 2 maal per week 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per week 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gewijzigd_toekomst_MA_wijziging | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 1 dag om 08:10 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 2 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 2 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Reden wijzigen of staken | |||
|style="background-color: white;"|te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 2 dagen, 1 maal per week 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per week 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gewijzigd_toekomst_MA_techstaken | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 1 dag om 08:10 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 11 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 1 dag om 00:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak stop type | |||
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur, 2 maal per week 1 stuk, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per week 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 11 dagen om 10:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 11 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 11 dagen, 2 maal per week 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per week 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA_wijziging | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 1 dag om 11:10 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 2 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 2 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak reden wijzigen of staken | |||
|style="background-color: white;"|te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 2 dagen, 1 maal per week 1 stuk, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per week 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|2.16.840.1.113883.2.4.3.11.999.77.16076005.1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA_techstaken | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 1 dag om 11:10 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 11 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 1 dag om 00:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak stop type | |||
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur, 2 maal per week 1 stuk, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per week 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_gewijzigd_toekomst /><section begin=MBH_MBH_300_NieuweMA /> | |||
====Medicamenteuze behandeling MBH_300_NieuweMA ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_NieuweMA_start_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 289 dagen om 11:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 289 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_NieuweMA_stop_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_stop_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 70 dagen om 13:45 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen, tot en met T - 71 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 289 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 71 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak stop type | |||
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Reden wijzigen of staken | |||
|style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_NieuweMA_nieuw_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 30 dagen om 10:45 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 30 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_NieuweMA_start_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 289 dagen om 11:31 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 289 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_NieuweMA_stop_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_stop_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 25 dagen om 15:55 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen, tot en met T - 71 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 289 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 71 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak stop type | |||
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak reden wijzigen of staken | |||
|style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_stop_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_NieuweMA_nieuw_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 25 dagen om 15:57 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 30 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_NieuweMA_start_MGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_start_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 289 dagen om 11:32 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 289 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_NieuweMA_nieuw_MGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 10 dagen om 13:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 30 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_NieuweMA /><section begin=MBH_MBH_300_OTCmedicatie /> | |||
====Medicamenteuze behandeling MBH_300_OTCmedicatie ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_OTCmedicatie_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 30 dagen om 10:45 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen, tot en met T - 16 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 30 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 16 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 30 dagen, tot en met T - 16 dagen, 2 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_OTCmedicatie_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_OTCmedicatie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 28 dagen om 14:35 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 28 dagen, tot en met T - 14 dagen om 00:00 uur'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 28 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 14 dagen om 00:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 28 dagen, tot en met T - 14 dagen om 00:00 uur, 2 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud1 | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_OTCmedicatie_MGB_oud1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 270 dagen om 16:03 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 280 dagen, tot en met T - 273 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 280 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 273 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 280 dagen, tot en met T - 273 dagen, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud2 | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_OTCmedicatie_MGB_oud2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 150 dagen om 11:59 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 155 dagen, tot en met T - 147 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 155 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 147 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 155 dagen, tot en met T - 147 dagen, 3 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|3 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud3 | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_OTCmedicatie_MGB_oud3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 29 dagen om 09:22 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 80 dagen, tot en met T - 75 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 80 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 75 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 80 dagen, tot en met T - 75 dagen, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_nieuw | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_OTCmedicatie_MGB_nieuw (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 16 dagen om 14:45 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 28 dagen, tot en met T - 14 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 28 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 14 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 28 dagen, tot en met T - 14 dagen, 2 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_OTCmedicatie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_OTCmedicatie /><section begin=MBH_MBH_300_ToekomstigEnNieuweMA /> | |||
====Medicamenteuze behandeling MBH_300_ToekomstigEnNieuweMA ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_startMA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 98 dagen om 15:11 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen, gedurende 50 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 98 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|50 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 98 dagen, gedurende 50 dagen, 2 maal per dag 2 stuks, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_ToekomstMA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 70 dagen om 14:44 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 10 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 10 dagen, 3 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|3 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_stopMA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 63 dagen om 09:13 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen, tot en met T - 63 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 98 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T - 63 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak stop type | |||
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 98 dagen, tot en met T - 63 dagen, 2 maal per dag 2 stuks, oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_NieuwMA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_NieuwMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 63 dagen om 09:15 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen, tot en met T + 9 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 30 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 9 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 30 dagen, tot en met T + 9 dagen, gedurende 39 dagen 2 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|gedurende 39 dagen 2 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_ToekomstigEnNieuweMA_startTA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 98 dagen om 15:15 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 98 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 98 dagen, 2 maal per dag 2 stuks, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_ToekomstigEnNieuweMA_ToekomstTA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 70 dagen om 14:45 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 10 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 10 dagen, 3 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|3 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_ToekomstigEnNieuweMA_startMGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 98 dagen om 15:20 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 98 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 98 dagen, 2 maal per dag 2 stuks, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_ToekomstigEnNieuweMA_ToekomstMGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 70 dagen om 14:50 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 10 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 10 dagen, 3 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|3 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_ToekomstigEnNieuweMA /><section begin=MBH_MBH_300_nieuweToekomstigeMA /> | |||
====Medicamenteuze behandeling MBH_300_nieuweToekomstigeMA ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_startMA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 20 dagen om 10:01 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|3 weken | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, gedurende 3 weken 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|gedurende 3 weken 1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_toekomstMA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 15 dagen om 13:26 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 1 week'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 1 dag | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|1 week | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_annuleerMA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_annuleerMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 5 dagen om 15:15 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 1 week'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 1 dag | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|1 week | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak stop type | |||
|style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_nieuwTMA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_nieuwTMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 5 dagen om 15:20 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 4 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 1 dag | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|4 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Reden wijzigen of staken | |||
|style="background-color: white;"|foutieve registratie van medicatie (code = '159691000146109' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 1 dag, gedurende 4 dagen, gedurende 4 dagen 1 maal per dag 2 stuks, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|gedurende 4 dagen 1 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_nieuweToekomstigeMA_startTA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 20 dagen om 10:05 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|3 weken | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, gedurende 3 weken 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|gedurende 3 weken 1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_nieuweToekomstigeMA_toekomstTA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 15 dagen om 13:30 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 1 week'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 1 dag | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|1 week | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_nieuweToekomstigeMA_startMGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 20 dagen om 10:10 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|3 weken | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, gedurende 3 weken 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|gedurende 3 weken 1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_nieuweToekomstigeMA_toekomstMGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 15 dagen om 13:35 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 1 week'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 1 dag | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|1 week | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie medicatieafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_nieuweToekomstigeMA /><section begin=MBH_MBH_300_stopMA_zonder_referentie /> | |||
====Medicamenteuze behandeling MBH_300_stopMA_zonder_referentie ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_stopMA_zonder_referentie_stopMA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 5 dagen om 13:55 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 2 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 14 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 2 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak stop type | |||
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 2 dagen, 1 maal per dag 1 stuk, Oraal, | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_stopMA_zonder_referentie_startMA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 5 dagen om 13:57 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 5 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 2 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 2 dagen, 1 maal per dag 1.5 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1.5 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_stopMA_zonder_referentie_toekomstMA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 5 dagen om 14:03 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T + 3 dagen, gedurende 3 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T + 3 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Gebruiksduur | |||
|style="background-color: white;"|3 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T + 3 dagen, gedurende 3 dagen, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_stopMA_zonder_referentie_TA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsafspraak datum tijd | |||
|style="background-color: white;"|T - 14 dagen om 15:14 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 2 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 14 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 2 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 2 dagen, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_stopMA_zonder_referentie_MGB | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatiegebruik datum tijd | |||
|style="background-color: white;"|T - 14 dagen om 15:20 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 2 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 14 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 2 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Informant | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Informant is patient | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 2 dagen, 1 maal per dag 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie toedieningsafspraak | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_300_stopMA_zonder_referentie /> | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Marcha_van_Partners" title="Intern ID = Marcha_van_Partners">Zorgverlener Marcha_van_Partners</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="7"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener identificatienummer | |||
|style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgegevens | |||
|style="background-color: white;"|Marcha van Partners | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Specialisme | |||
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Itis|Zorgaanbieder: Huisartsenpraktijk_Itis]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="7"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener identificatienummer | |||
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgegevens | |||
|style="background-color: white;"|Peter van Pulver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Specialisme | |||
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Jan_van_Harten" title="Intern ID = Jan_van_Harten">Zorgverlener Jan_van_Harten</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="7"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener identificatienummer | |||
|style="background-color: white;"|000002222 (in identificerend systeem: UZI Personen) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgegevens | |||
|style="background-color: white;"|Jan van Harten | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Specialisme | |||
|style="background-color: white;"|Medisch specialisten, chirurgie (code = '0303' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#Ziekenhuis_het_Gele_Hart|Zorgaanbieder: Ziekenhuis_het_Gele_Hart]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Huisartsenpraktijk_Itis" title="Intern ID = Huisartsenpraktijk_Itis">Zorgaanbieder Huisartsenpraktijk_Itis</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|00005111 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Huisartsenpraktijk Itis | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Apotheek De Gulle Gaper | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|99901111 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Apotheek Jansen en Co | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|<span id="Ziekenhuis_het_Gele_Hart" title="Intern ID = Ziekenhuis_het_Gele_Hart">Zorgaanbieder Ziekenhuis_het_Gele_Hart</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="5"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|00004444 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Ziekenhuis het Gele Hart | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Groenestraat 1 1200AA Hartstad | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie type | |||
|style="background-color: white;"|Ziekenhuis (code = 'V4' in codeSystem '2.16.840.1.113883.2.4.15.1060') | |||
|}<section end=ALLMBHS_XXX_Dijk /> | |||
==Patiënt H. XXX_Hoek== | |||
<section begin=XXX_Hoek /> | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Naamgegevens | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="6"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Initialen | |||
|style="background-color: white;"|H. | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgebruik | |||
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geslachtsnaam | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Achternaam | |||
|style="background-color: white;"|XXX_Hoek | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatienummer | |||
|style="background-color: white;"|999900638 [BSN] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geboortedatum | |||
|style="background-color: white;"|5 nov 1963 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geslacht | |||
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
|}<section end=XXX_Hoek /><section begin=ALLMBHS_XXX_Hoek /><section begin=MBH_MBH_300_contactepisode /> | |||
====Medicamenteuze behandeling MBH_300_contactepisode ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_contactepisode_MA | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_300_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Medicatieafspraak datum tijd | |||
|style="background-color: white;"|T - 20 dagen om 08:00 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen'' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingangsdatum | |||
|style="background-color: white;"|T - 20 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Einddatum | |||
|style="background-color: white;"|T + 9 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgverlener | |||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie contact | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatienummer | |||
|style="background-color: white;"|MBH_300_contactepisode_CONTACT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie zorgepisode | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatienummer | |||
|style="background-color: white;"|MBH_300_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_300_contactepisode_WDS_opstartschema | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
Versie van 21 jul 2023 09:54
__NUMBEREDHEADINGS__
1 Addenda voor inhoudelijke gegevens[bewerken]
1.1 Patiënt L. van de XXX_Meijsz[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | L. | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Meijsz | |||
| Adresgegevens | Knolweg 1003 9999ZA Apeldoorn Apeldoorn 157 Nederland 3 Woon-/verblijfadres | |||
| Identificatienummer | 999900821 [BSN] | |||
| Geboortedatum | 27 okt 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.1.1 Medicamenteuze behandeling MBH_300_hybride_voorschrift[bewerken]
| Medicatieafspraak MBH_300_hybride_voorschrift_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_hybride_voorschrift_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak datum tijd | T - 1 dag om 12:10 uur | |||
| Gebruiksperiode | Vanaf T, tot en met T + 7 dagen | |||
| Ingangsdatum | T | |||
| Einddatum | T + 7 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Hannie_Huiske | |||
| Geneesmiddel - primaire code | TRIMETHOPRIM TABLET 300MG (code = '16020' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | TRIMETHOPRIM TABLET 300MG (code = '39136' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T, tot en met T + 7 dagen, 1 maal per dag 2 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 2 stuks | |||
| MBH identificatie | MBH_300_hybride_voorschrift (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_hybride_voorschrift_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_hybride_voorschrift_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T - 1 dag om 12:10 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Hannie_Huiske | |||
| Te verstrekken hoeveelheid | 14 stuks | |||
| Geneesmiddel - primaire code | TRIMETHOPRIM TABLET 300MG (code = '16020' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | TRIMETHOPRIM TABLET 300MG (code = '39136' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_hybride_voorschrift_MA | |||
| MBH identificatie | MBH_300_hybride_voorschrift (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.1.2 Medicamenteuze behandeling MBH_300_hybride_generiekeTA[bewerken]
| Toedieningsafspraak 16020 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | 16020 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 1 dag om 15:10 uur | |||
| Gebruiksperiode | Vanaf T, tot en met T + 7 dagen | |||
| Ingangsdatum | T | |||
| Einddatum | T + 7 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T, tot en met T + 7 dagen, 1 maal per dag 2 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 2 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | Vooraankondiging_PresciptionID (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| MBH identificatie | MBH_300_hybride_generiekeTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener Hannie_Huiske | ||||
| Zorgverlener identificatienummer | 000004449 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Hannie H. Huiske | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: huisartsencentrum_Huiske | |||
| Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
| Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
| Organisatie naam | Apotheek De Gulle Gaper | |||
| Zorgaanbieder huisartsencentrum_Huiske | ||||
| Zorgaanbieder identificatienummer | 00003336 (in identificerend systeem: URA) | |||
| Organisatie naam | huisartsencentrum Huiske | |||
| Afdeling specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
1.2 Patiënt B. XXX_Blik[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | B. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Blik | |||
| Identificatienummer | 999900389 [BSN] | |||
| Geboortedatum | 13 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.2.1 Medicamenteuze behandeling MBH_300_QA1[bewerken]
| Medicatieafspraak MBH_300_QA1_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 20 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 9 dagen | |||
| Ingangsdatum | T - 20 dagen | |||
| Einddatum | T + 9 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_QA1_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T - 20 dagen om 08:00 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Te verstrekken hoeveelheid | 60 stuks | |||
| Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_QA1_MA | |||
| MBH identificatie | MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_QA1_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 20 dagen om 09:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 9 dagen | |||
| Ingangsdatum | T - 20 dagen | |||
| Einddatum | T + 9 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_QA1_MVE | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Medicatieverstrekkings datum tijd | T - 20 dagen om 09:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 60 stuks | |||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
| Relatie verstrekkingsverzoek | MBH_300_QA1_VV | |||
| MBH identificatie | MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_QA1_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 1 dag om 10:04:23 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 9 dagen | |||
| Ingangsdatum | T - 20 dagen | |||
| Einddatum | T + 9 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.2.2 Medicamenteuze behandeling MBH_300_QA2[bewerken]
| Medicatieafspraak MBH_300_QA2_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 100 dagen om 08:04 uur | |||
| Gebruiksperiode | Vanaf T - 100 dagen, tot en met T - 72 dagen | |||
| Ingangsdatum | T - 100 dagen | |||
| Einddatum | T - 72 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 10 ml | |||
| MBH identificatie | MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_QA2_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T - 100 dagen om 08:04 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Te verstrekken hoeveelheid | 300 ml | |||
| Geneesmiddel - primaire code | SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_QA2_MA | |||
| MBH identificatie | MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_QA2_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 100 dagen om 09:04 uur | |||
| Gebruiksperiode | Vanaf T - 100 dagen, tot en met T - 72 dagen | |||
| Ingangsdatum | T - 100 dagen | |||
| Einddatum | T - 72 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 10 ml | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_QA2_MVE | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Medicatieverstrekkings datum tijd | T - 100 dagen om 09:04 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 300 ml | |||
| Geneesmiddel - primaire code | XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |||
| Relatie verstrekkingsverzoek | MBH_300_QA2_VV | |||
| MBH identificatie | MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_QA2_MGB | |||||
| Gegevenselement | Waarde | ||||
| Identificatie | MBH_300_QA2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||
| Medicatiegebruik datum tijd | T - 68 dagen om 12:13:55 uur | ||||
| Gebruik indicator | Ja | ||||
| Volgens afspraak indicator | Ja | ||||
| Gebruiksperiode | Vanaf T - 100 dagen, tot en met T - 72 dagen | ||||
| Ingangsdatum | T - 100 dagen | ||||
| Einddatum | T - 72 dagen | ||||
| Voorschrijver | |||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||||
| Auteur | |||||
| Auteur is zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | ||||
| Geneesmiddel - primaire code | XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') | ||||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||||
| Gebruiksinstructie | |||||
| Omschrijving | Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 millimeter, oraal | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
| Doseerinstructie | 1 maal per dag 10 millimeter | ||||
| Relatie toedieningsafspraak | |||||
| Identificatie | MBH_300_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
| MBH identificatie | MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||||
1.2.3 Medicamenteuze behandeling MBH_300_QA3[bewerken]
| Medicatieafspraak MBH_300_QA3_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 50 dagen om 08:10 uur | |||
| Gebruiksperiode | Vanaf T - 50 dagen, tot en met T - 11 dagen | |||
| Ingangsdatum | T - 50 dagen | |||
| Einddatum | T - 11 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per dag 50 ml | |||
| MBH identificatie | MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_QA3_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA3_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T - 50 dagen om 08:10 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Te verstrekken hoeveelheid | 4000 ml | |||
| Geneesmiddel - primaire code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_QA3_MA | |||
| MBH identificatie | MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_QA3_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 50 dagen om 09:10 uur | |||
| Gebruiksperiode | Vanaf T - 50 dagen, tot en met T - 11 dagen | |||
| Ingangsdatum | T - 50 dagen | |||
| Einddatum | T - 11 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per dag 50 ml | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_QA3_MVE | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA3_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Medicatieverstrekkings datum tijd | T - 50 dagen om 09:10 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 4000 ml | |||
| Geneesmiddel - primaire code | NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |||
| Relatie verstrekkingsverzoek | MBH_300_QA3_VV | |||
| MBH identificatie | MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_QA3_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 9 dagen om 07:59:59 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 50 dagen, tot en met T - 11 dagen | |||
| Ingangsdatum | T - 50 dagen | |||
| Einddatum | T - 11 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 50 ml | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.2.4 Medicamenteuze behandeling MBH_300_QA4[bewerken]
| Medicatieafspraak MBH_300_QA4_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 10 dagen om 08:12 uur | |||
| Gebruiksperiode | Vanaf T - 10 dagen, tot en met T + 19 dagen | |||
| Ingangsdatum | T - 10 dagen | |||
| Einddatum | T + 19 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_QA4_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA4_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T - 10 dagen om 08:12 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Te verstrekken hoeveelheid | 30 stuks | |||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_QA4_MA | |||
| MBH identificatie | MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_QA4_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 10 dagen om 09:12 uur | |||
| Gebruiksperiode | Vanaf T - 10 dagen, tot en met T + 19 dagen | |||
| Ingangsdatum | T - 10 dagen | |||
| Einddatum | T + 19 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_QA4_MVE | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA4_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Medicatieverstrekkings datum tijd | T - 10 dagen om 09:12 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 30 stuks | |||
| Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |||
| Relatie verstrekkingsverzoek | MBH_300_QA4_VV | |||
| MBH identificatie | MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_QA4_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 2 dagen om 08:12 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 10 dagen, tot en met T + 19 dagen | |||
| Ingangsdatum | T - 10 dagen | |||
| Einddatum | T + 19 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.2.5 Medicamenteuze behandeling MBH_300_QA5[bewerken]
| Medicatieafspraak MBH_300_QA5_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 50 dagen om 08:15 uur | |||
| Gebruiksperiode | Vanaf T - 50 dagen, gedurende 7 dagen | |||
| Ingangsdatum | T - 50 dagen | |||
| Gebruiksduur | 7 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 4 maal per dag 2 stuks | |||
| MBH identificatie | MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_QA5_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA5_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T - 50 dagen om 08:15 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Te verstrekken hoeveelheid | 56 stuks | |||
| Geneesmiddel - primaire code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_QA5_MA | |||
| MBH identificatie | MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_QA5_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 50 dagen om 09:15 uur | |||
| Gebruiksperiode | Vanaf T - 50 dagen, gedurende 7 dagen | |||
| Ingangsdatum | T - 50 dagen | |||
| Gebruiksduur | 7 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 4 maal per dag 2 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_QA5_MVE | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA5_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Medicatieverstrekkings datum tijd | T - 50 dagen om 09:15 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 56 stuks | |||
| Geneesmiddel - primaire code | PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
| Relatie verstrekkingsverzoek | MBH_300_QA5_VV | |||
| MBH identificatie | MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_QA5_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA5_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 43 dagen om 08:00 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 50 dagen, gedurende 7 dagen | |||
| Ingangsdatum | T - 50 dagen | |||
| Gebruiksduur | 7 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 4 maal per dag 2 stuks | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.2.6 Medicamenteuze behandeling MBH_300_QA6[bewerken]
| Medicatieafspraak MBH_300_QA6_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 5 dagen om 08:18 uur | |||
| Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 1 dag | |||
| Ingangsdatum | T - 5 dagen | |||
| Einddatum | T + 1 dag | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_QA6_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA6_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T - 5 dagen om 08:18 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Te verstrekken hoeveelheid | 21 stuks | |||
| Geneesmiddel - primaire code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_QA6_MA | |||
| MBH identificatie | MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_QA6_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA6_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 5 dagen om 09:18 uur | |||
| Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 1 dag | |||
| Ingangsdatum | T - 5 dagen | |||
| Einddatum | T + 1 dag | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_QA6_MVE | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA6_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Medicatieverstrekkings datum tijd | T - 5 dagen om 09:18 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 21 stuks | |||
| Geneesmiddel - primaire code | OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |||
| Relatie verstrekkingsverzoek | MBH_300_QA6_VV | |||
| MBH identificatie | MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_QA6_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA6_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 2 dagen om 08:59:59 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 1 dag | |||
| Ingangsdatum | T - 5 dagen | |||
| Einddatum | T + 1 dag | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.2.7 Medicamenteuze behandeling MBH_300_QA7[bewerken]
| Wisselend doseerschema MBH_300_QA7_WDS | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA7_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| Wisselend doseerschema datum tijd | T - 30 dagen om 10:11 uur | |||
| Gebruiksperiode | Vanaf T - 30 dagen, gedurende 2 weken | |||
| Ingangsdatum | T - 30 dagen | |||
| Gebruiksduur | 2 weken | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Tanja_de_Bakker | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 30 dagen, gedurende 2 weken, eerst gedurende 4 dagen 1 maal per dag om 18:00 3 stuks, dan gedurende 6 dagen 1 maal per dag om 18:00 2 stuks, dan gedurende 4 dagen 1 maal per dag om 18:00 3 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 4 dagen 1 maal per dag om 18:00 3 stuks | |||
| Doseerinstructie 2 | dan gedurende 6 dagen 1 maal per dag om 18:00 2 stuks | |||
| Doseerinstructie 3 | dan gedurende 4 dagen 1 maal per dag om 18:00 3 stuks | |||
| Toelichting | gemeten INR waarde: 2,3 | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_QA7_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_QA7 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.2.8 Medicamenteuze behandeling MBH_300_QA8[bewerken]
| Wisselend doseerschema MBH_300_QA8_WDS | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA8_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| Wisselend doseerschema datum tijd | T - 40 dagen om 11:33 uur | |||
| Gebruiksperiode | Vanaf T - 40 dagen, gedurende 1 week | |||
| Ingangsdatum | T - 40 dagen | |||
| Gebruiksduur | 1 week | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Tanja_de_Bakker | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 40 dagen, gedurende 1 week, cyclus van 3 dagen: steeds eerst gedurende 2 dagen 1 maal per dag om 18:00 3 stuks, dan gedurende 1 dag 1 maal per dag om 18:00 2 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 2 dagen 1 maal per dag om 18:00 3 stuks | |||
| Doseerinstructie 2 | dan gedurende 1 dag 1 maal per dag om 18:00 2 stuks | |||
| Herhaalperiode cyclisch schema | 3 dagen | |||
| Toelichting | gemeten INR waarde: 2,8 | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_QA8_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_QA8 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.2.9 Medicamenteuze behandeling MBH_300_QA9[bewerken]
| Wisselend doseerschema MBH_300_QA9_WDS | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA9_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| Wisselend doseerschema datum tijd | T - 15 dagen om 14:44 uur | |||
| Gebruiksperiode | Vanaf T - 15 dagen, gedurende 10 dagen | |||
| Ingangsdatum | T - 15 dagen | |||
| Gebruiksduur | 10 dagen | |||
| Wisselend doseerschema stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Tanja_de_Bakker | |||
| Geneesmiddel - primaire code | FENPRCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FENPRCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 15 dagen, gedurende 10 dagen, eerst gedurende 8 dagen 1 maal per dag 1 stuk, dan gedurende 2 dagen 1 maal per dag 0 stuks, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 8 dagen 1 maal per dag 1 stuk | |||
| Doseerinstructie 2 | dan gedurende 2 dagen 1 maal per dag 0 stuks | |||
| Toelichting | gemeten INR waarde: 2,1 | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_QA9_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_QA9 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.2.10 Medicamenteuze behandeling MBH_300_QA10[bewerken]
| Wisselend doseerschema MBH_300_QA10_WDS | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA10_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| Wisselend doseerschema datum tijd | T - 5 dagen om 13:55 uur | |||
| Gebruiksperiode | Vanaf T - 5 dagen, gedurende 4 dagen | |||
| Ingangsdatum | T - 5 dagen | |||
| Gebruiksduur | 4 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Tanja_de_Bakker | |||
| Geneesmiddel - primaire code | FENPRCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FENPRCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 5 dagen, gedurende 4 dagen, gedurende 4 dagen 1 maal per dag om 18:00 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 4 dagen 1 maal per dag om 18:00 1 stuk | |||
| Toelichting | gemeten INR waarde: 2,5 | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_QA10_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_QA10 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.2.11 Medicamenteuze behandeling MBH_300_QA11[bewerken]
| Wisselend doseerschema MBH_300_QA11_WDS | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA11_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| Wisselend doseerschema datum tijd | T - 60 dagen om 10:44 uur | |||
| Gebruiksperiode | Vanaf T - 60 dagen, gedurende 8 dagen | |||
| Ingangsdatum | T - 60 dagen | |||
| Gebruiksduur | 8 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Tanja_de_Bakker | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 60 dagen, gedurende 8 dagen, eerst gedurende 5 dagen 1 maal per dag 4 stuks, dan gedurende 3 dagen 1 maal per dag 3 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 5 dagen 1 maal per dag 4 stuks | |||
| Doseerinstructie 2 | dan gedurende 3 dagen 1 maal per dag 3 stuks | |||
| Toelichting | gemeten INR waarde: 2,2 | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_QA11_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_QA11 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.2.12 Medicamenteuze behandeling MBH_300_QA12[bewerken]
| Wisselend doseerschema MBH_300_QA12_WDS | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_QA12_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| Wisselend doseerschema datum tijd | T - 74 dagen om 09:11 uur | |||
| Gebruiksperiode | Vanaf T - 74 dagen, tot en met T - 61 dagen | |||
| Ingangsdatum | T - 74 dagen | |||
| Einddatum | T - 61 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Tanja_de_Bakker | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 74 dagen, tot en met T - 61 dagen, cyclus van 7 dagen: steeds eerst gedurende 2 dagen 1 maal per dag 5 stuks, dan gedurende 5 dagen 1 maal per dag 3 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 2 dagen 1 maal per dag 5 stuks | |||
| Doseerinstructie 2 | dan gedurende 5 dagen 1 maal per dag 3 stuks | |||
| Herhaalperiode cyclisch schema | 7 dagen | |||
| Toelichting | gemeten INR waarde: 2,7 | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_QA12_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_QA12 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener Peter_van_Pulver | ||||
| Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
| Zorgverlener Tanja_de_Bakker | ||||
| Zorgverlener identificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Tanja de Bakker | |||
| Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Trombosedienst_Ons_Dorp | |||
| Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
| Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
| Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
| Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
| Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
| Organisatie naam | Apotheek De Gulle Gaper | |||
| Zorgaanbieder Trombosedienst_Ons_Dorp | ||||
| Zorgaanbieder identificatienummer | 11112222 (in identificerend systeem: URA) | |||
| Organisatie naam | Trombosedienst Ons Dorp | |||
| Afdeling specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Adresgegevens | : Kerkstraat 28 d 1332GH Ons Dorp | |||
1.3 Patiënt R. van XXX_Sonnenberg[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | 1 | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Sonnenberg | |||
| Identificatienummer | 999901084 [BSN] | |||
| Geboortedatum | 1985-11-20 | |||
| Geslacht | 2 | |||
1.4 Patiënt C. XXX_Brugge[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.4.1 Medicamenteuze behandeling MBH_300_start_eind[bewerken]
| Medicatieafspraak MBH_300_start_eind_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 10 dagen om 11:20 uur | |||
| Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 5 dagen | |||
| Ingangsdatum | T - 10 dagen | |||
| Einddatum | T - 5 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_start_eind_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T - 10 dagen om 11:20 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Te verstrekken hoeveelheid | 5 stuks | |||
| Geneesmiddel - primaire code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_start_eind_MA | |||
| MBH identificatie | MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_start_eind_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 10 dagen om 12:20 uur | |||
| Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 5 dagen | |||
| Ingangsdatum | T - 10 dagen | |||
| Einddatum | T - 5 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_start_eind_MVE | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_eind_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Medicatieverstrekkings datum tijd | T - 10 dagen om 12:20 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 5 stuks | |||
| Geneesmiddel - primaire code | METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | |||
| Relatie verstrekkingsverzoek | MBH_300_start_eind_VV | |||
| MBH identificatie | MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_start_eind_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_eind_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 4 dagen om 10:59:59 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 5 dagen | |||
| Ingangsdatum | T - 10 dagen | |||
| Einddatum | T - 5 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Geneesmiddel - primaire code | METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 stuk | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_start_eind_MGB_patient | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_eind_MGB_patient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 4 dagen om 10:59:59 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 5 dagen | |||
| Ingangsdatum | T - 10 dagen | |||
| Einddatum | T - 5 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Auteur | ||||
| Auteur is patient | Ja | |||
| Geneesmiddel - primaire code | METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 stuk | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.4.2 Medicamenteuze behandeling MBH_300_start_duur[bewerken]
| Medicatieafspraak MBH_300_start_duur_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 20 dagen om 11:30 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, gedurende 3 weken | |||
| Ingangsdatum | T - 20 dagen | |||
| Gebruiksduur | 3 weken | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_start_duur_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_duur_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T om 11:30 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Te verstrekken hoeveelheid | 21 stuks | |||
| Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | |||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_start_duur_MA | |||
| MBH identificatie | MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_start_duur_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_duur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 20 dagen om 12:30 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, gedurende 3 weken | |||
| Ingangsdatum | T - 20 dagen | |||
| Gebruiksduur | 3 weken | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | |||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_start_duur_MVE | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_duur_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Medicatieverstrekkings datum tijd | T - 20 dagen om 12:30 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 21 stuks | |||
| Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | |||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
| Relatie verstrekkingsverzoek | MBH_300_start_duur_VV | |||
| MBH identificatie | MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_start_duur_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_duur_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 1 dag om 12:00 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 20 dagen, gedurende 3 weken | |||
| Ingangsdatum | T - 20 dagen | |||
| Gebruiksduur | 3 weken | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.4.3 Medicamenteuze behandeling MBH_300_chronisch[bewerken]
| Medicatieafspraak MBH_300_chronisch_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 30 dagen om 11:32 uur | |||
| Gebruiksperiode | Vanaf T - 30 dagen | |||
| Ingangsdatum | T - 30 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_chronisch_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_chronisch_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T - 30 dagen om 11:32 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Te verstrekken hoeveelheid | 21 stuks | |||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_chronisch_MA | |||
| MBH identificatie | MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_chronisch_VV_extraVVbestaandeMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_chronisch_VV_extraVVbestaandeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T - 10 dagen om 11:35 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Te verstrekken hoeveelheid | 90 stuks | |||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_chronisch_MA | |||
| MBH identificatie | MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_chronisch_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 30 dagen om 12:32 uur | |||
| Gebruiksperiode | Vanaf T - 30 dagen | |||
| Ingangsdatum | T - 30 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_chronisch_MVE | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_chronisch_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Medicatieverstrekkings datum tijd | T - 30 dagen om 12:32 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 21 stuks | |||
| Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
| Relatie verstrekkingsverzoek | MBH_300_chronisch_VV | |||
| MBH identificatie | MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_chronisch_MVE_extraMVEbestaandeTA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_chronisch_MVE_extraMVEbestaandeTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Medicatieverstrekkings datum tijd | T - 10 dagen om 12:35 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 90 stuks | |||
| Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
| Relatie verstrekkingsverzoek | MBH_300_chronisch_VV_extraVVbestaandeMA | |||
| MBH identificatie | MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_chronisch_MGB | |||||
| Gegevenselement | Waarde | ||||
| Identificatie | MBH_300_chronisch_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||
| Medicatiegebruik datum tijd | T - 20 dagen om 11:43:12 uur | ||||
| Gebruik indicator | Ja | ||||
| Volgens afspraak indicator | Ja | ||||
| Gebruiksperiode | Vanaf T - 30 dagen | ||||
| Ingangsdatum | T - 30 dagen | ||||
| Voorschrijver | |||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||||
| Informant | |||||
| Informant is patient | Ja | ||||
| Auteur | |||||
| Auteur is zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Itis | ||||
| Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||||
| Gebruiksinstructie | |||||
| Omschrijving | Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
| Doseerinstructie | 1 maal per dag 1 stuk | ||||
| Relatie toedieningsafspraak | |||||
| Identificatie | MBH_300_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
| MBH identificatie | MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||||
| Medicatiegebruik MBH_300_chronisch_MGB_patient | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_chronisch_MGB_patient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 20 dagen om 11:43:12 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 30 dagen | |||
| Ingangsdatum | T - 30 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Auteur | ||||
| Auteur is patient | Ja | |||
| Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_chronisch_MGB_informant_Zorgverlener | |||||
| Gegevenselement | Waarde | ||||
| Identificatie | MBH_300_chronisch_MGB_informant_Zorgverlener (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||
| Medicatiegebruik datum tijd | T - 10 dagen om 11:43:12 uur | ||||
| Gebruik indicator | Ja | ||||
| Volgens afspraak indicator | Ja | ||||
| Voorschrijver | |||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||||
| Informant | |||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | ||||
| Auteur | |||||
| Auteur is zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | ||||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||||
| Gebruiksinstructie | |||||
| Omschrijving | oraal | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
| Relatie toedieningsafspraak | |||||
| Identificatie | MBH_300_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
| MBH identificatie | MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||||
1.4.4 Medicamenteuze behandeling MBH_300_start_duur2[bewerken]
| Medicatieafspraak MBH_300_start_duur2_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 60 dagen om 11:30 uur | |||
| Gebruiksperiode | Vanaf T - 60 dagen, gedurende 28 dagen | |||
| Ingangsdatum | T - 60 dagen | |||
| Gebruiksduur | 28 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_start_duur2_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_duur2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T - 60 dagen om 11:30 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Te verstrekken hoeveelheid | 28 stuks | |||
| Geneesmiddel - primaire code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_start_duur2_MA | |||
| MBH identificatie | MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_start_duur2_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_duur2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 60 dagen om 12:30 uur | |||
| Gebruiksperiode | Vanaf T - 60 dagen, gedurende 28 dagen | |||
| Ingangsdatum | T - 60 dagen | |||
| Gebruiksduur | 28 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_start_duur2_MVE | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_duur2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Medicatieverstrekkings datum tijd | T - 60 dagen om 12:30 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 28 stuks | |||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
| Relatie verstrekkingsverzoek | MBH_300_start_duur2_VV | |||
| MBH identificatie | MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_start_duur2_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_start_duur2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 55 dagen om 15:21:33 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 60 dagen, gedurende 28 dagen | |||
| Ingangsdatum | T - 60 dagen | |||
| Gebruiksduur | 28 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.4.5 Medicamenteuze behandeling MBH_300_dosis_stuks[bewerken]
| Medicatieafspraak MBH_300_dosis_stuks_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 130 dagen om 11:35 uur | |||
| Gebruiksperiode | Vanaf T - 130 dagen, tot en met T - 101 dagen | |||
| Ingangsdatum | T - 130 dagen | |||
| Einddatum | T - 101 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie | |||
| Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 1 dosis | |||
| MBH identificatie | MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_dosis_stuks_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_dosis_stuks_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T - 130 dagen om 11:35 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Te verstrekken hoeveelheid | 1 stuk | |||
| Geneesmiddel - primaire code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_dosis_stuks_MA | |||
| MBH identificatie | MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_dosis_stuks_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_dosis_stuks_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 130 dagen om 12:35 uur | |||
| Gebruiksperiode | Vanaf T - 130 dagen, tot en met T - 101 dagen | |||
| Ingangsdatum | T - 130 dagen | |||
| Einddatum | T - 101 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie | |||
| Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 1 dosis | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_dosis_stuks_MVE | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_dosis_stuks_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Medicatieverstrekkings datum tijd | T - 130 dagen om 12:35 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 1 stuk | |||
| Geneesmiddel - primaire code | FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |||
| Relatie verstrekkingsverzoek | MBH_300_dosis_stuks_VV | |||
| MBH identificatie | MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_dosis_stuks_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_dosis_stuks_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 100 dagen om 07:59:59 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per dag 1 dosis, inhalatie | |||
| Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 1 dosis | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.4.6 Medicamenteuze behandeling MBH_300_nieuweMBHobvTA[bewerken]
| Toedieningsafspraak MBH_300_nieuweMBHobvTA_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweMBHobvTA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 10 dagen om 10:00 uur | |||
| Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 5 dagen | |||
| Ingangsdatum | T - 10 dagen | |||
| Einddatum | T - 5 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | PARACETAMOL APOTEX TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | PARACETAMOL TABLET 500MG (code = '67903' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PARACETAMOL TABLET 500MG (code = '2194' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 10 dagen, tot en met T - 5 dagen, Zo nodig 3 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | Zo nodig 3 maal per dag 2 stuks | |||
| MBH identificatie | MBH_300_nieuweMBHobvTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_nieuweMBHobvTA_MVE | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweMBHobvTA_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekkings datum tijd | T - 10 dagen om 10:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 30 stuks | |||
| Geneesmiddel - primaire code | PARACETAMOL APOTEX TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | PARACETAMOL TABLET 500MG (code = '67903' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PARACETAMOL TABLET 500MG (code = '2194' in codeSystem 'G-Standaard GPK') | |||
| MBH identificatie | MBH_300_nieuweMBHobvTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_nieuweMBHobvTA_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweMBHobvTA_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 3 dagen om 16:00 uur | |||
| Gebruik indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 10 dagen om 10:00 uur, tot en met T - 3 dagen om 16:00 uur | |||
| Ingangsdatum | T - 10 dagen om 10:00 uur | |||
| Einddatum | T - 3 dagen om 16:00 uur | |||
| Auteur | ||||
| Auteur is patient | Ja | |||
| Geneesmiddel - primaire code | PARACETAMOL APOTEX TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | PARACETAMOL TABLET 500MG (code = '67903' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PARACETAMOL TABLET 500MG (code = '2194' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 10 dagen om 10:00 uur, tot en met T - 3 dagen om 16:00 uur, 3 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 3 maal per dag 2 stuks | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_nieuweMBHobvTA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_nieuweMBHobvTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.4.7 Medicamenteuze behandeling MBH_300_WDS_start_duur[bewerken]
| Wisselend doseerschema MBH_300_WDS_start_duur_WDS | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_start_duur_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| Wisselend doseerschema datum tijd | T - 10 dagen om 11:30 uur | |||
| Gebruiksperiode | Vanaf T - 10 dagen, gedurende 2 weken | |||
| Ingangsdatum | T - 10 dagen | |||
| Gebruiksduur | 2 weken | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 10 dagen, gedurende 2 weken, eerst gedurende 1 dag 1 maal per dag 2 stuks, dan gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 1 stuk, dan gedurende 6 dagen 1 maal per dag 3 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 1 dag 1 maal per dag 2 stuks | |||
| Doseerinstructie 2 | dan gedurende 6 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 3 | dan gedurende 1 dag 1 maal per dag 1 stuk | |||
| Doseerinstructie 4 | dan gedurende 6 dagen 1 maal per dag 3 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_WDS_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.4.8 Medicamenteuze behandeling MBH_300_WDS_start_duur2[bewerken]
| Wisselend doseerschema MBH_300_WDS_start_duur2_WDS | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_start_duur2_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| Wisselend doseerschema datum tijd | T - 15 dagen om 11:30 uur | |||
| Gebruiksperiode | Vanaf T - 15 dagen, gedurende 13 dagen | |||
| Ingangsdatum | T - 15 dagen | |||
| Gebruiksduur | 13 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 15 dagen, gedurende 13 dagen, gedurende 13 dagen 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 13 dagen 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_WDS_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener Peter_van_Pulver | ||||
| Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
| Zorgverlener Marcha_van_Partners | ||||
| Zorgverlener identificatienummer | 000001115 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Marcha van Partners | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Itis | |||
| Zorgverlener Tanja_de_Bakker | ||||
| Zorgverlener identificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Tanja de Bakker | |||
| Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Trombosedienst_Ons_Dorp | |||
| Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
| Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
| Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
| Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
| Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
| Organisatie naam | Apotheek De Gulle Gaper | |||
| Zorgaanbieder Huisartsenpraktijk_Itis | ||||
| Zorgaanbieder identificatienummer | 00005111 (in identificerend systeem: URA) | |||
| Organisatie naam | Huisartsenpraktijk Itis | |||
| Adresgegevens | Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
| Zorgaanbieder Trombosedienst_Ons_Dorp | ||||
| Zorgaanbieder identificatienummer | 11112222 (in identificerend systeem: URA) | |||
| Organisatie naam | Trombosedienst Ons Dorp | |||
| Afdeling specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Adresgegevens | : Kerkstraat 28 d 1332GH Ons Dorp | |||
1.5 Patiënt M. XXX_Niesing[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Niesing | |||
| Identificatienummer | 999900845 [BSN] | |||
| Geboortedatum | 29 okt 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.5.1 Medicamenteuze behandeling MBH_300_HPKvoorschrijven[bewerken]
| Medicatieafspraak MBH_300_HPKvoorschrijven_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 170 dagen om 13:00 uur | |||
| Gebruiksperiode | Vanaf T - 170 dagen, tot en met T - 21 dagen | |||
| Ingangsdatum | T - 170 dagen | |||
| Einddatum | T - 21 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_HPKvoorschrijven_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_HPKvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T - 170 dagen om 13:00 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Te verstrekken hoeveelheid | 150 stuks | |||
| Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_HPKvoorschrijven_MA | |||
| MBH identificatie | MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_HPKvoorschrijven_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 170 dagen om 14:00 uur | |||
| Gebruiksperiode | Vanaf T - 170 dagen, tot en met T - 21 dagen | |||
| Ingangsdatum | T - 170 dagen | |||
| Einddatum | T - 21 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_HPKvoorschrijven_MVE | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_HPKvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Medicatieverstrekkings datum tijd | T - 170 dagen om 14:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 150 stuks | |||
| Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
| Relatie verstrekkingsverzoek | MBH_300_HPKvoorschrijven_VV | |||
| MBH identificatie | MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_HPKvoorschrijven_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_HPKvoorschrijven_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T om 22:08 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T, tot en met T | |||
| Ingangsdatum | T | |||
| Einddatum | T | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_HPKvoorschrijven_MGB_patient | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_HPKvoorschrijven_MGB_patient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T om 22:08 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T, tot en met T | |||
| Ingangsdatum | T | |||
| Einddatum | T | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Auteur | ||||
| Auteur is patient | Ja | |||
| Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.5.2 Medicamenteuze behandeling MBH_300_ZINRvoorschrijven[bewerken]
| Medicatieafspraak MBH_300_ZINRvoorschrijven_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T om 13:05 uur | |||
| Gebruiksperiode | Vanaf T, tot en met T + 150 dagen | |||
| Ingangsdatum | T | |||
| Einddatum | T + 150 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_ZINRvoorschrijven_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ZINRvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T om 13:05 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Te verstrekken hoeveelheid | 150 stuks | |||
| Geneesmiddel - primaire code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_ZINRvoorschrijven_MA | |||
| MBH identificatie | MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_ZINRvoorschrijven_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T om 14:05 uur | |||
| Gebruiksperiode | Vanaf T, tot en met T + 150 dagen | |||
| Ingangsdatum | T | |||
| Einddatum | T + 150 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_ZINRvoorschrijven_MVE | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ZINRvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Medicatieverstrekkings datum tijd | T om 14:05 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 150 stuks | |||
| Geneesmiddel - primaire code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
| Relatie verstrekkingsverzoek | MBH_300_ZINRvoorschrijven_VV | |||
| MBH identificatie | MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_ZINRvoorschrijven_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ZINRvoorschrijven_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T om 22:08 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T, tot en met T | |||
| Ingangsdatum | T | |||
| Einddatum | T | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_ZINRvoorschrijven_MGB_patient | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ZINRvoorschrijven_MGB_patient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T om 22:08 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T, tot en met T | |||
| Ingangsdatum | T | |||
| Einddatum | T | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Auteur | ||||
| Auteur is patient | Ja | |||
| Geneesmiddel - primaire code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.5.3 Medicamenteuze behandeling MBH_300_WDSmetHPK[bewerken]
| Wisselend doseerschema MBH_300_WDSmetHPK_WDS | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDSmetHPK_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| Wisselend doseerschema datum tijd | T - 3 dagen om 16:25 uur | |||
| Gebruiksperiode | Vanaf T - 3 dagen, gedurende 7 dagen | |||
| Ingangsdatum | T - 3 dagen | |||
| Gebruiksduur | 7 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | MARCOUMAR TABLET 3MG (code = '52477' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 3 dagen, gedurende 7 dagen, eerst gedurende 3 dagen 1 maal per dag 0.5 stuk, dan gedurende 1 dag 1 maal per dag 0 stuks, dan gedurende 2 dagen 1 maal per dag 0.5 stuk, dan gedurende 1 dag 1 maal per dag 0 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 3 dagen 1 maal per dag 0.5 stuk | |||
| Doseerinstructie 2 | dan gedurende 1 dag 1 maal per dag 0 stuks | |||
| Doseerinstructie 3 | dan gedurende 2 dagen 1 maal per dag 0.5 stuk | |||
| Doseerinstructie 4 | dan gedurende 1 dag 1 maal per dag 0 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_WDSmetHPK_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDSmetHPK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener Peter_van_Pulver | ||||
| Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
| Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
| Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
| Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
| Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
| Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
| Organisatie naam | Apotheek De Gulle Gaper | |||
1.6 Patiënt J. XXX_Bree[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | J. | |||
| Naamgebruik | 1 | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Bree | |||
| Identificatienummer | 999901588 [BSN] | |||
| Geboortedatum | 2010-07-01 | |||
| Geslacht | 2 | |||
1.7 Patiënt M. XXX_Pherai[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Pherai | |||
| Identificatienummer | 999900870 [BSN] | |||
| Geboortedatum | 1 nov 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.7.1 Medicamenteuze behandeling MBH_300_wdsmtd1[bewerken]
| Medicatieafspraak MBH_300_wdsmtd1_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 20 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen | |||
| Ingangsdatum | T - 20 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| MBH identificatie | MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Wisselend doseerschema MBH_300_wdsmtd1_WDS_opstartschema | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| Wisselend doseerschema datum tijd | T - 20 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, tot en met T - 15 dagen | |||
| Ingangsdatum | T - 20 dagen | |||
| Einddatum | T - 15 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, tot en met T - 15 dagen, eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks, dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks | |||
| Doseerinstructie 2 | dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Wisselend doseerschema MBH_300_wdsmtd1_WDS_trombosedienst | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| Wisselend doseerschema datum tijd | T - 15 dagen om 14:30 uur | |||
| Gebruiksperiode | Vanaf T - 14 dagen, tot en met T - 5 dagen | |||
| Ingangsdatum | T - 14 dagen | |||
| Einddatum | T - 5 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Tanja_de_Bakker | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 14 dagen, tot en met T - 5 dagen, cyclus van 5 dagen: steeds eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds | |||
| Doseerinstructie 2 | dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds | |||
| Doseerinstructie 3 | dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds | |||
| Herhaalperiode cyclisch schema | 5 dagen | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie wisselend doseerschema | ||||
| Identificatie | MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| MBH identificatie | MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Wisselend doseerschema MBH_300_wdsmtd1_WDS_technischestop | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_wdsmtd1_WDS_technischestop (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| Wisselend doseerschema datum tijd | T - 7 dagen om 10:30 uur | |||
| Gebruiksperiode | Vanaf T - 14 dagen, tot en met T - 7 dagen | |||
| Ingangsdatum | T - 14 dagen | |||
| Einddatum | T - 7 dagen | |||
| Wisselend doseerschema stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Tanja_de_Bakker | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 14 dagen, tot en met T - 7 dagen, cyclus van 5 dagen: steeds eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds | |||
| Doseerinstructie 2 | dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds | |||
| Doseerinstructie 3 | dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds | |||
| Herhaalperiode cyclisch schema | 5 dagen | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie wisselend doseerschema | ||||
| Identificatie | MBH_300_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| MBH identificatie | MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Wisselend doseerschema MBH_300_wdsmtd1_WDS_verhoging | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_wdsmtd1_WDS_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| Wisselend doseerschema datum tijd | T - 7 dagen om 10:30 uur | |||
| Gebruiksperiode | Vanaf T - 6 dagen, tot en met T + 3 dagen | |||
| Ingangsdatum | T - 6 dagen | |||
| Einddatum | T + 3 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Tanja_de_Bakker | |||
| Reden wijzigen of staken | gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 6 dagen, tot en met T + 3 dagen, cyclus van 5 dagen: steeds eerst gedurende 3 dagen 1 maal per dag om 19:00 2 stuks, dan gedurende 2 dagen 1 maal per dag om 19:00 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 3 dagen 1 maal per dag om 19:00 2 stuks | |||
| Doseerinstructie 2 | dan gedurende 2 dagen 1 maal per dag om 19:00 1 stuk | |||
| Herhaalperiode cyclisch schema | 5 dagen | |||
| Toelichting | Dosering aangepast i.v.m. te lage INR waarde. | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie wisselend doseerschema | ||||
| Identificatie | MBH_300_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| MBH identificatie | MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_wdsmtd1_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_wdsmtd1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| Verstrekkingsverzoek datum tijd | T - 20 dagen om 08:00 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Te verstrekken hoeveelheid | 60 stuks | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Beoogd verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Relatie medicatieafspraak | MBH_300_wdsmtd1_MA | |||
| MBH identificatie | MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_wdsmtd1_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_wdsmtd1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 20 dagen om 09:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen | |||
| Ingangsdatum | T - 20 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieverstrekking MBH_300_wdsmtd1_MVE | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_wdsmtd1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| Medicatieverstrekkings datum tijd | T - 20 dagen om 09:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Verstrekte hoeveelheid | 60 stuks | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Relatie verstrekkingsverzoek | MBH_300_wdsmtd1_VV | |||
| MBH identificatie | MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatietoediening MBH_300_wdsmtd1_MTD1 | |||||
| Gegevenselement | Waarde | ||||
| Identificatie | MBH_300_wdsmtd1_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||||
| Toedienings datum tijd | T - 20 dagen om 20:30 uur | ||||
| Afgesproken datum tijd | T - 20 dagen om 20:00 uur | ||||
| Volgens afspraak indicator | Ja | ||||
| Toegediende hoeveelheid | |||||
| Aantal | 1 | ||||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
| Afgesproken hoeveelheid | |||||
| Aantal | 2 | ||||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
| Toedieningsweg | ORAAL (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
| Toediener | |||||
| Mantelzorger | |||||
| Contactpersoon | Zie Contactpersoon: Toos_de_Bakker | ||||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||||
| Relatie wisselend doseerschema | |||||
| Identificatie | MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||||
| MBH identificatie | MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||||
| Medicatietoediening MBH_300_wdsmtd1_MTD2 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_wdsmtd1_MTD2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| Toedienings datum tijd | T - 19 dagen om 20:00 uur | |||
| Afgesproken datum tijd | T - 19 dagen om 20:00 uur | |||
| Volgens afspraak indicator | Nee | |||
| Toegediende hoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Afgesproken hoeveelheid | ||||
| Aantal | 2 | |||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Toediener | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Thuiszorg_Om_en_Bij | |||
| Medicatietoediening reden van afwijken | toediening van medicatie geweigerd (code = '406149000' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Relatie wisselend doseerschema | ||||
| Identificatie | MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| MBH identificatie | MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatietoediening MBH_300_wdsmtd1_MTD3 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_wdsmtd1_MTD3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| Toedienings datum tijd | T - 17 dagen om 20:00 uur | |||
| Afgesproken datum tijd | T - 17 dagen om 20:00 uur | |||
| Volgens afspraak indicator | Nee | |||
| Toegediende hoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Afgesproken hoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Toediener | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Thuiszorg_Om_en_Bij | |||
| Medicatietoediening reden van afwijken | niet in staat om medicatie te gebruiken (code = '408366001' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Toelichting | Geprobeerd, maar niet gelukt met de tablet | |||
| Relatie wisselend doseerschema | ||||
| Identificatie | MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| MBH identificatie | MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatietoediening MBH_300_wdsmtd1_MTD4 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_wdsmtd1_MTD4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| Toedienings datum tijd | T - 16 dagen om 20:05 uur | |||
| Afgesproken datum tijd | T - 16 dagen om 20:00 uur | |||
| Volgens afspraak indicator | Nee | |||
| Toegediende hoeveelheid | ||||
| Aantal | 0 | |||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Afgesproken hoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Toediener | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Thuiszorg_Om_en_Bij | |||
| Medicatietoediening reden van afwijken | zorgafnemer niet beschikbaar om medicatie in ontvangst te nemen (code = '153241000146104' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Relatie wisselend doseerschema | ||||
| Identificatie | MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| MBH identificatie | MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Contactpersoon Toos_de_Bakker | ||||
| Naamgegevens | Toos de Bakker | |||
| Rol | Mantelzorger (code = '100001' in codeSystem '2.16.840.1.113883.2.4.3.11.60.40.4.23.1') | |||
| Zorgverlener Peter_van_Pulver | ||||
| Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
| Zorgverlener Tanja_de_Bakker | ||||
| Zorgverlener identificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Tanja de Bakker | |||
| Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Trombosedienst_Ons_Dorp | |||
| Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
| Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
| Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
| Zorgaanbieder Trombosedienst_Ons_Dorp | ||||
| Zorgaanbieder identificatienummer | 11112222 (in identificerend systeem: URA) | |||
| Organisatie naam | Trombosedienst Ons Dorp | |||
| Afdeling specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Adresgegevens | : Kerkstraat 28 d 1332GH Ons Dorp | |||
| Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
| Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
| Organisatie naam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
| Zorgaanbieder Thuiszorg_Om_en_Bij | ||||
| Zorgaanbieder identificatienummer | 11110000 (in identificerend systeem: URA) | |||
| Organisatie naam | Thuiszorg Om en Bij | |||
| Organisatie type | Thuiszorg (code = 'T2' in codeSystem '2.16.840.1.113883.2.4.15.1060') | |||
1.8 Patiënt M. van de XXX_Roelofs[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | 1 | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Roelofs | |||
| Identificatienummer | 999900973 [BSN] | |||
| Geboortedatum | 1985-11-10 | |||
| Geslacht | 2 | |||
1.9 Patiënt C. XXX_Dijk[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Dijk | |||
| Identificatienummer | 999900456 [BSN] | |||
| Geboortedatum | 20 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.9.1 Medicamenteuze behandeling MBH_300_gestopt[bewerken]
| Medicatieafspraak MBH_300_gestopt_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 4 maanden om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 4 maanden, tot en met T + 5 maanden | |||
| Ingangsdatum | T - 4 maanden | |||
| Einddatum | T + 5 maanden | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Geneesmiddel - primaire code | OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 4 maanden, tot en met T + 5 maanden, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gestopt_MA_staken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 10 dagen om 18:00 uur | |||
| Gebruiksperiode | Vanaf T - 4 maanden, tot en met T - 10 dagen | |||
| Ingangsdatum | T - 4 maanden | |||
| Einddatum | T - 10 dagen | |||
| Medicatieafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Reden wijzigen of staken | geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gestopt_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 4 maanden om 09:00 uur | |||
| Gebruiksperiode | Vanaf T - 4 maanden, tot en met T + 5 maanden | |||
| Ingangsdatum | T - 4 maanden | |||
| Einddatum | T + 5 maanden | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 4 maanden, tot en met T + 5 maanden, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gestopt_TA_staken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestopt_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 10 dagen om 19:00 uur | |||
| Gebruiksperiode | Vanaf T - 4 maanden, tot en met T - 10 dagen | |||
| Ingangsdatum | T - 4 maanden | |||
| Einddatum | T - 10 dagen | |||
| Toedieningsafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.2 Medicamenteuze behandeling MBH_300_gewijzigd[bewerken]
| Medicatieafspraak MBH_300_gewijzigd_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 21 dagen om 08:02 uur | |||
| Gebruiksperiode | Vanaf T - 21 dagen | |||
| Ingangsdatum | T - 21 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Geneesmiddel - primaire code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gewijzigd_MA_wijziging | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 2 dagen om 08:02 uur | |||
| Gebruiksperiode | Vanaf T - 2 dagen | |||
| Ingangsdatum | T - 2 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Reden wijzigen of staken | gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 2 dagen, 2 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gewijzigd_MA_techstaken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 2 dagen om 08:02 uur | |||
| Gebruiksperiode | Vanaf T - 21 dagen, tot en met T - 3 dagen | |||
| Ingangsdatum | T - 21 dagen | |||
| Einddatum | T - 3 dagen | |||
| Medicatieafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Geneesmiddel - primaire code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigd_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 21 dagen om 09:02 uur | |||
| Gebruiksperiode | Vanaf T - 21 dagen | |||
| Ingangsdatum | T - 21 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigd_TA_wijziging | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 2 dagen om 09:02 uur | |||
| Gebruiksperiode | Vanaf T - 2 dagen | |||
| Ingangsdatum | T - 2 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 2 dagen, 2 maal per dag 2 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per dag 2 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigd_TA_techstaken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 2 dagen om 09:02 uur | |||
| Gebruiksperiode | Vanaf T - 21 dagen, tot en met T - 3 dagen | |||
| Ingangsdatum | T - 21 dagen | |||
| Einddatum | T - 3 dagen | |||
| Toedieningsafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.3 Medicamenteuze behandeling MBH_300_gewijzigddoorander[bewerken]
| Medicatieafspraak MBH_300_gewijzigddoorander_MA_eigen | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 60 dagen om 08:05 uur | |||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T + 14 dagen | |||
| Ingangsdatum | T - 60 dagen | |||
| Einddatum | T + 14 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 60 dagen, tot en met T + 14 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gewijzigddoorander_MA_wijzigingdoorander | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 3 dagen om 08:10 uur | |||
| Gebruiksperiode | Vanaf T - 3 dagen, tot en met T + 30 dagen | |||
| Ingangsdatum | T - 3 dagen | |||
| Einddatum | T + 30 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Reden wijzigen of staken | gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 3 dagen, tot en met T + 30 dagen, 1 maal per dag 2 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 2 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gewijzigddoorander_MA_techstakendoorander | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 3 dagen om 08:10 uur | |||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T - 4 dagen | |||
| Ingangsdatum | T - 60 dagen | |||
| Einddatum | T - 4 dagen | |||
| Medicatieafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 60 dagen, tot en met T - 4 dagen, 1 maal per dag 1 stuk, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigddoorander_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 60 dagen om 09:05 uur | |||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T + 14 dagen | |||
| Ingangsdatum | T - 60 dagen | |||
| Einddatum | T + 14 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 60 dagen, tot en met T + 14 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigddoorander_TA_wijziging | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 3 dagen om 09:10 uur | |||
| Gebruiksperiode | Vanaf T - 3 dagen, tot en met T + 30 dagen | |||
| Ingangsdatum | T - 3 dagen | |||
| Einddatum | T + 30 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 3 dagen, tot en met T + 30 dagen, 1 maal per dag 2 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 2 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigddoorander_TA_techstaken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 3 dagen om 09:10 uur | |||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T - 4 dagen | |||
| Ingangsdatum | T - 60 dagen | |||
| Einddatum | T - 4 dagen | |||
| Toedieningsafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 60 dagen, tot en met T - 4 dagen, 1 maal per dag 1 stuk, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_gewijzigddoorander_MGB_zv | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 3 dagen om 08:08 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T - 3 dagen | |||
| Ingangsdatum | T - 60 dagen | |||
| Einddatum | T - 3 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 60 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_gewijzigddoorander_MGB_pat | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T om 08:08 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 3 dagen, tot en met T - 1 dag | |||
| Ingangsdatum | T - 3 dagen | |||
| Einddatum | T - 1 dag | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Auteur | ||||
| Auteur is patient | Ja | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 3 dagen, tot en met T - 1 dag, 1 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 2 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.4 Medicamenteuze behandeling MBH_300_onderbroken[bewerken]
| Medicatieafspraak MBH_300_onderbroken_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 153 dagen om 08:06 uur | |||
| Gebruiksperiode | Vanaf T - 153 dagen, tot en met T + 20 dagen | |||
| Ingangsdatum | T - 153 dagen | |||
| Einddatum | T + 20 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Geneesmiddel - primaire code | FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 153 dagen, tot en met T + 20 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_onderbroken_MA_onderbreken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 100 dagen om 18:12 uur | |||
| Gebruiksperiode | Vanaf T - 153 dagen, tot en met T - 100 dagen | |||
| Ingangsdatum | T - 153 dagen | |||
| Einddatum | T - 100 dagen | |||
| Medicatieafspraak stop type | onderbroken (code = '385655000' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Reden wijzigen of staken | verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 153 dagen, tot en met T - 100 dagen, 1 maal per dag 1 stuk, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_onderbroken_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 153 dagen om 09:06 uur | |||
| Gebruiksperiode | Vanaf T - 153 dagen, tot en met T + 20 dagen | |||
| Ingangsdatum | T - 153 dagen | |||
| Einddatum | T + 20 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 153 dagen, tot en met T + 20 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_onderbroken_TA_onderbreken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_onderbroken_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 100 dagen om 19:12 uur | |||
| Gebruiksperiode | Vanaf T - 153 dagen, tot en met T - 100 dagen | |||
| Ingangsdatum | T - 153 dagen | |||
| Einddatum | T - 100 dagen | |||
| Toedieningsafspraak stop type | onderbroken (code = '385655000' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 153 dagen, tot en met T - 100 dagen, 1 maal per dag 1 stuk, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.5 Medicamenteuze behandeling MBH_300_andermans1[bewerken]
| Medicatieafspraak MBH_300_andermans1_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_andermans1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 10 dagen om 18:05 uur | |||
| Gebruiksperiode | Vanaf T - 9 dagen, tot en met T + 15 dagen | |||
| Ingangsdatum | T - 9 dagen | |||
| Einddatum | T + 15 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Jan_van_Harten | |||
| Geneesmiddel - primaire code | PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 9 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_andermans1_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_andermans1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 10 dagen om 18:45 uur | |||
| Gebruiksperiode | Vanaf T - 9 dagen, tot en met T + 15 dagen | |||
| Ingangsdatum | T - 9 dagen | |||
| Einddatum | T + 15 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | PANTOPRAZOL TEVA TABLET MSR 20MG (code = '2002914' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 9 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_andermans1_MGB_zv | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_andermans1_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T om 08:08 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 9 dagen, tot en met T | |||
| Ingangsdatum | T - 9 dagen | |||
| Einddatum | T | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Jan_van_Harten | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Jan_van_Harten | |||
| Geneesmiddel - primaire code | PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 9 dagen, tot en met T, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_andermans1_MGB_pat | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_andermans1_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T om 18:08 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 9 dagen, tot en met T | |||
| Ingangsdatum | T - 9 dagen | |||
| Einddatum | T | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Jan_van_Harten | |||
| Auteur | ||||
| Auteur is patient | Ja | |||
| Geneesmiddel - primaire code | PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 9 dagen, tot en met T, 1 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 2 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.6 Medicamenteuze behandeling MBH_300_andermans2[bewerken]
| Medicatieafspraak MBH_300_andermans2_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_andermans2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 159 dagen om 08:15 uur | |||
| Gebruiksperiode | Vanaf T - 159 dagen, gedurende 1 week | |||
| Ingangsdatum | T - 159 dagen | |||
| Gebruiksduur | 1 week | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Jan_van_Harten | |||
| Geneesmiddel - primaire code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 159 dagen, gedurende 1 week, 3 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_andermans2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_andermans2_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_andermans2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 159 dagen om 09:15 uur | |||
| Gebruiksperiode | Vanaf T - 159 dagen, gedurende 1 week | |||
| Ingangsdatum | T - 159 dagen | |||
| Gebruiksduur | 1 week | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 159 dagen, gedurende 1 week, 3 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_eigen2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_andermans2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.7 Medicamenteuze behandeling MBH_300_gebruik[bewerken]
| Medicatiegebruik MBH_300_gebruik_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gebruik_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 1 dag om 08:12 uur | |||
| Gebruik indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 2 dagen | |||
| Ingangsdatum | T - 10 dagen | |||
| Einddatum | T - 2 dagen | |||
| Auteur | ||||
| Auteur is patient | Ja | |||
| Geneesmiddel - Product specificatie | ||||
| Product naam | Paracetamol 500mg | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 10 dagen, tot en met T - 2 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_gebruik (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.8 Medicamenteuze behandeling MBH_300_geannuleerd[bewerken]
| Medicatieafspraak MBH_300_geannuleerd_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_geannuleerd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 2 dagen om 18:15 uur | |||
| Gebruiksperiode | Vanaf T + 5 dagen | |||
| Ingangsdatum | T + 5 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 5 dagen, 2 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_geannuleerd_MA_annuleren | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_geannuleerd_MA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 1 dag om 15:30 uur | |||
| Gebruiksperiode | Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur | |||
| Ingangsdatum | T + 5 dagen | |||
| Einddatum | T + 5 dagen om 00:00 uur | |||
| Medicatieafspraak stop type | geannuleerd (code = '89925002' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Reden wijzigen of staken | medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur, 2 maal per dag 1 stuk, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard ') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_geannuleerd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_geannuleerd_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_geannuleerd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 2 dagen om 19:05 uur | |||
| Gebruiksperiode | Vanaf T + 5 dagen | |||
| Ingangsdatum | T + 5 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | |||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 5 dagen, 2 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_andermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_geannuleerd_TA_annuleren | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_geannuleerd_TA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 1 dag om 16:45 uur | |||
| Gebruiksperiode | Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur | |||
| Ingangsdatum | T + 5 dagen | |||
| Einddatum | T + 5 dagen om 00:00 uur | |||
| Toedieningsafspraak stop type | geannuleerd (code = '89925002' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | |||
| Toedieningsafspraak reden wijzigen of staken | medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur, 2 maal per dag 1 stuk, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_geannuleerd_MA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_geannuleerd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.9 Medicamenteuze behandeling MBH_300_toekomstig[bewerken]
| Medicatieafspraak MBH_300_toekomstig_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 1 dag om 08:15 uur | |||
| Gebruiksperiode | Vanaf T + 15 dagen, tot en met T + 51 dagen | |||
| Ingangsdatum | T + 15 dagen | |||
| Einddatum | T + 51 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Geneesmiddel - primaire code | DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 15 dagen, tot en met T + 51 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_toekomstig_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_toekomstig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 1 dag om 09:15 uur | |||
| Gebruiksperiode | Vanaf T + 15 dagen, tot en met T + 51 dagen | |||
| Ingangsdatum | T + 15 dagen | |||
| Einddatum | T + 51 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | DOXYCYCLINE PCH TABLET 100MG (code = '1141317' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 15 dagen, tot en met T + 51 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.10 Medicamenteuze behandeling MBH_300_gestoptandermans[bewerken]
| Medicatieafspraak MBH_300_gestoptandermans_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 20 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 7 dagen | |||
| Ingangsdatum | T - 20 dagen | |||
| Einddatum | T + 7 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, tot en met T + 7 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gestoptandermans_MA_staken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 10 dagen om 18:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, tot en met T - 10 dagen | |||
| Ingangsdatum | T - 20 dagen | |||
| Einddatum | T - 10 dagen | |||
| Medicatieafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Reden wijzigen of staken | geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gestoptandermans_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 20 dagen om 09:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 7 dagen | |||
| Ingangsdatum | T - 20 dagen | |||
| Einddatum | T + 7 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, tot en met T + 7 dagen, 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gestoptandermans_TA_staken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestoptandermans_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 10 dagen om 19:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, tot en met T - 10 dagen | |||
| Ingangsdatum | T - 20 dagen | |||
| Einddatum | T - 10 dagen | |||
| Toedieningsafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.11 Medicamenteuze behandeling MBH_300_gewijzigd_toekomst[bewerken]
| Medicatieafspraak MBH_300_gewijzigd_toekomst_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 11 dagen om 08:20 uur | |||
| Gebruiksperiode | Vanaf T - 11 dagen | |||
| Ingangsdatum | T - 11 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Geneesmiddel - primaire code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 11 dagen, 2 maal per week 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per week 1 stuk | |||
| MBH identificatie | MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gewijzigd_toekomst_MA_wijziging | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_toekomst_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 1 dag om 08:10 uur | |||
| Gebruiksperiode | Vanaf T + 2 dagen | |||
| Ingangsdatum | T + 2 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Reden wijzigen of staken | te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 2 dagen, 1 maal per week 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per week 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gewijzigd_toekomst_MA_techstaken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_toekomst_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 1 dag om 08:10 uur | |||
| Gebruiksperiode | Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur | |||
| Ingangsdatum | T - 11 dagen | |||
| Einddatum | T + 1 dag om 00:00 uur | |||
| Medicatieafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
| Geneesmiddel - primaire code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur, 2 maal per week 1 stuk, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per week 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 11 dagen om 10:30 uur | |||
| Gebruiksperiode | Vanaf T - 11 dagen | |||
| Ingangsdatum | T - 11 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 11 dagen, 2 maal per week 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per week 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA_wijziging | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_toekomst_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 1 dag om 11:10 uur | |||
| Gebruiksperiode | Vanaf T + 2 dagen | |||
| Ingangsdatum | T + 2 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Toedieningsafspraak reden wijzigen of staken | te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 2 dagen, 1 maal per week 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per week 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | 2.16.840.1.113883.2.4.3.11.999.77.16076005.1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA_techstaken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_toekomst_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 1 dag om 11:10 uur | |||
| Gebruiksperiode | Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur | |||
| Ingangsdatum | T - 11 dagen | |||
| Einddatum | T + 1 dag om 00:00 uur | |||
| Toedieningsafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur, 2 maal per week 1 stuk, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per week 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.12 Medicamenteuze behandeling MBH_300_NieuweMA[bewerken]
| Medicatieafspraak MBH_300_NieuweMA_start_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 289 dagen om 11:30 uur | |||
| Gebruiksperiode | Vanaf T - 289 dagen | |||
| Ingangsdatum | T - 289 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_NieuweMA_stop_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_stop_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 70 dagen om 13:45 uur | |||
| Gebruiksperiode | Vanaf T - 289 dagen, tot en met T - 71 dagen | |||
| Ingangsdatum | T - 289 dagen | |||
| Einddatum | T - 71 dagen | |||
| Medicatieafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Reden wijzigen of staken | medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_NieuweMA_nieuw_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 30 dagen om 10:45 uur | |||
| Gebruiksperiode | Vanaf T - 30 dagen | |||
| Ingangsdatum | T - 30 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_NieuweMA_start_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 289 dagen om 11:31 uur | |||
| Gebruiksperiode | Vanaf T - 289 dagen | |||
| Ingangsdatum | T - 289 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_NieuweMA_stop_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_stop_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 25 dagen om 15:55 uur | |||
| Gebruiksperiode | Vanaf T - 289 dagen, tot en met T - 71 dagen | |||
| Ingangsdatum | T - 289 dagen | |||
| Einddatum | T - 71 dagen | |||
| Toedieningsafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Toedieningsafspraak reden wijzigen of staken | medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_NieuweMA_stop_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_NieuweMA_nieuw_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 25 dagen om 15:57 uur | |||
| Gebruiksperiode | Vanaf T - 30 dagen | |||
| Ingangsdatum | T - 30 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_NieuweMA_start_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_start_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 289 dagen om 11:32 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 289 dagen | |||
| Ingangsdatum | T - 289 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_NieuweMA_nieuw_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_nieuw_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 10 dagen om 13:30 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 30 dagen | |||
| Ingangsdatum | T - 30 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.13 Medicamenteuze behandeling MBH_300_OTCmedicatie[bewerken]
| Medicatieafspraak MBH_300_OTCmedicatie_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 30 dagen om 10:45 uur | |||
| Gebruiksperiode | Vanaf T - 30 dagen, tot en met T - 16 dagen | |||
| Ingangsdatum | T - 30 dagen | |||
| Einddatum | T - 16 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 30 dagen, tot en met T - 16 dagen, 2 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_OTCmedicatie_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_OTCmedicatie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 28 dagen om 14:35 uur | |||
| Gebruiksperiode | Vanaf T - 28 dagen, tot en met T - 14 dagen om 00:00 uur | |||
| Ingangsdatum | T - 28 dagen | |||
| Einddatum | T - 14 dagen om 00:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 28 dagen, tot en met T - 14 dagen om 00:00 uur, 2 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud1 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_OTCmedicatie_MGB_oud1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 270 dagen om 16:03 uur | |||
| Gebruik indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 280 dagen, tot en met T - 273 dagen | |||
| Ingangsdatum | T - 280 dagen | |||
| Einddatum | T - 273 dagen | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 280 dagen, tot en met T - 273 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud2 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_OTCmedicatie_MGB_oud2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 150 dagen om 11:59 uur | |||
| Gebruik indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 155 dagen, tot en met T - 147 dagen | |||
| Ingangsdatum | T - 155 dagen | |||
| Einddatum | T - 147 dagen | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 155 dagen, tot en met T - 147 dagen, 3 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud3 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_OTCmedicatie_MGB_oud3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 29 dagen om 09:22 uur | |||
| Gebruik indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 80 dagen, tot en met T - 75 dagen | |||
| Ingangsdatum | T - 80 dagen | |||
| Einddatum | T - 75 dagen | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 80 dagen, tot en met T - 75 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_OTCmedicatie_MGB_nieuw | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_OTCmedicatie_MGB_nieuw (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 16 dagen om 14:45 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 28 dagen, tot en met T - 14 dagen | |||
| Ingangsdatum | T - 28 dagen | |||
| Einddatum | T - 14 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 28 dagen, tot en met T - 14 dagen, 2 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_OTCmedicatie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.14 Medicamenteuze behandeling MBH_300_ToekomstigEnNieuweMA[bewerken]
| Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_startMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 98 dagen om 15:11 uur | |||
| Gebruiksperiode | Vanaf T - 98 dagen, gedurende 50 dagen | |||
| Ingangsdatum | T - 98 dagen | |||
| Gebruiksduur | 50 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 98 dagen, gedurende 50 dagen, 2 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 2 stuks | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_ToekomstMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 70 dagen om 14:44 uur | |||
| Gebruiksperiode | Vanaf T + 10 dagen | |||
| Ingangsdatum | T + 10 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 10 dagen, 3 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_stopMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 63 dagen om 09:13 uur | |||
| Gebruiksperiode | Vanaf T - 98 dagen, tot en met T - 63 dagen | |||
| Ingangsdatum | T - 98 dagen | |||
| Einddatum | T - 63 dagen | |||
| Medicatieafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 98 dagen, tot en met T - 63 dagen, 2 maal per dag 2 stuks, oraal, | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 2 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_NieuwMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_NieuwMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 63 dagen om 09:15 uur | |||
| Gebruiksperiode | Vanaf T - 30 dagen, tot en met T + 9 dagen | |||
| Ingangsdatum | T - 30 dagen | |||
| Einddatum | T + 9 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 30 dagen, tot en met T + 9 dagen, gedurende 39 dagen 2 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 39 dagen 2 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_ToekomstigEnNieuweMA_startTA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 98 dagen om 15:15 uur | |||
| Gebruiksperiode | Vanaf T - 98 dagen | |||
| Ingangsdatum | T - 98 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 98 dagen, 2 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 2 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_ToekomstigEnNieuweMA_ToekomstTA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_ToekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 70 dagen om 14:45 uur | |||
| Gebruiksperiode | Vanaf T + 10 dagen | |||
| Ingangsdatum | T + 10 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 10 dagen, 3 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_ToekomstigEnNieuweMA_startMGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_startMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 98 dagen om 15:20 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 98 dagen | |||
| Ingangsdatum | T - 98 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 98 dagen, 2 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 2 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_ToekomstigEnNieuweMA_ToekomstMGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_ToekomstMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 70 dagen om 14:50 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T + 10 dagen | |||
| Ingangsdatum | T + 10 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 10 dagen, 3 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_ToekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.15 Medicamenteuze behandeling MBH_300_nieuweToekomstigeMA[bewerken]
| Medicatieafspraak MBH_300_nieuweToekomstigeMA_startMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 20 dagen om 10:01 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, gedurende 3 weken | |||
| Ingangsdatum | T - 20 dagen | |||
| Gebruiksduur | 3 weken | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, gedurende 3 weken, gedurende 3 weken 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 3 weken 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_nieuweToekomstigeMA_toekomstMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 15 dagen om 13:26 uur | |||
| Gebruiksperiode | Vanaf T + 1 dag, gedurende 1 week | |||
| Ingangsdatum | T + 1 dag | |||
| Gebruiksduur | 1 week | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 1 week 1 maal per dag 3 stuks | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_nieuweToekomstigeMA_annuleerMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_annuleerMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 5 dagen om 15:15 uur | |||
| Gebruiksperiode | Vanaf T + 1 dag, gedurende 1 week | |||
| Ingangsdatum | T + 1 dag | |||
| Gebruiksduur | 1 week | |||
| Medicatieafspraak stop type | geannuleerd (code = '89925002' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal, | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 1 week 1 maal per dag 3 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_nieuweToekomstigeMA_nieuwTMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_nieuwTMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 5 dagen om 15:20 uur | |||
| Gebruiksperiode | Vanaf T + 1 dag, gedurende 4 dagen | |||
| Ingangsdatum | T + 1 dag | |||
| Gebruiksduur | 4 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Reden wijzigen of staken | foutieve registratie van medicatie (code = '159691000146109' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 1 dag, gedurende 4 dagen, gedurende 4 dagen 1 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 4 dagen 1 maal per dag 2 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_nieuweToekomstigeMA_startTA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 20 dagen om 10:05 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, gedurende 3 weken | |||
| Ingangsdatum | T - 20 dagen | |||
| Gebruiksduur | 3 weken | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, gedurende 3 weken, gedurende 3 weken 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 3 weken 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_nieuweToekomstigeMA_toekomstTA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_toekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 15 dagen om 13:30 uur | |||
| Gebruiksperiode | Vanaf T + 1 dag, gedurende 1 week | |||
| Ingangsdatum | T + 1 dag | |||
| Gebruiksduur | 1 week | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 1 week 1 maal per dag 3 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_nieuweToekomstigeMA_startMGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_startMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 20 dagen om 10:10 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 20 dagen, gedurende 3 weken | |||
| Ingangsdatum | T - 20 dagen | |||
| Gebruiksduur | 3 weken | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, gedurende 3 weken, gedurende 3 weken 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 3 weken 1 maal per dag 1 stuk | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_nieuweToekomstigeMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_nieuweToekomstigeMA_toekomstMGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_toekomstMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 15 dagen om 13:35 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T + 1 dag, gedurende 1 week | |||
| Ingangsdatum | T + 1 dag | |||
| Gebruiksduur | 1 week | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 1 week 1 maal per dag 3 stuks | |||
| Relatie medicatieafspraak | ||||
| Identificatie | MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_nieuweToekomstigeMA_toekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.16 Medicamenteuze behandeling MBH_300_stopMA_zonder_referentie[bewerken]
| Medicatieafspraak MBH_300_stopMA_zonder_referentie_stopMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_stopMA_zonder_referentie_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 5 dagen om 13:55 uur | |||
| Gebruiksperiode | Vanaf T - 14 dagen, tot en met T + 2 dagen | |||
| Ingangsdatum | T - 14 dagen | |||
| Einddatum | T + 2 dagen | |||
| Medicatieafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 14 dagen, tot en met T + 2 dagen, 1 maal per dag 1 stuk, Oraal, | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_stopMA_zonder_referentie_startMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_stopMA_zonder_referentie_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 5 dagen om 13:57 uur | |||
| Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 2 dagen | |||
| Ingangsdatum | T - 5 dagen | |||
| Einddatum | T + 2 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 5 dagen, tot en met T + 2 dagen, 1 maal per dag 1.5 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1.5 stuk | |||
| MBH identificatie | MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_stopMA_zonder_referentie_toekomstMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_stopMA_zonder_referentie_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 5 dagen om 14:03 uur | |||
| Gebruiksperiode | Vanaf T + 3 dagen, gedurende 3 dagen | |||
| Ingangsdatum | T + 3 dagen | |||
| Gebruiksduur | 3 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T + 3 dagen, gedurende 3 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_stopMA_zonder_referentie_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_stopMA_zonder_referentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| Toedieningsafspraak datum tijd | T - 14 dagen om 15:14 uur | |||
| Gebruiksperiode | Vanaf T - 14 dagen, tot en met T + 2 dagen | |||
| Ingangsdatum | T - 14 dagen | |||
| Einddatum | T + 2 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 14 dagen, tot en met T + 2 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_stopMA_zonder_referentie_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_stopMA_zonder_referentie_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Medicatiegebruik datum tijd | T - 14 dagen om 15:20 uur | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Ja | |||
| Gebruiksperiode | Vanaf T - 14 dagen, tot en met T + 2 dagen | |||
| Ingangsdatum | T - 14 dagen | |||
| Einddatum | T + 2 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Informant | ||||
| Informant is patient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 14 dagen, tot en met T + 2 dagen, 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Relatie toedieningsafspraak | ||||
| Identificatie | MBH_300_stopMA_zonder_referentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener Marcha_van_Partners | ||||
| Zorgverlener identificatienummer | 000001115 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Marcha van Partners | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Itis | |||
| Zorgverlener Peter_van_Pulver | ||||
| Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
| Zorgverlener Jan_van_Harten | ||||
| Zorgverlener identificatienummer | 000002222 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jan van Harten | |||
| Specialisme | Medisch specialisten, chirurgie (code = '0303' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: Ziekenhuis_het_Gele_Hart | |||
| Zorgaanbieder Huisartsenpraktijk_Itis | ||||
| Zorgaanbieder identificatienummer | 00005111 (in identificerend systeem: URA) | |||
| Organisatie naam | Huisartsenpraktijk Itis | |||
| Adresgegevens | Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
| Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
| Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
| Organisatie naam | Apotheek De Gulle Gaper | |||
| Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
| Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
| Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
| Zorgaanbieder Apotheek_Jansen_en_Co | ||||
| Zorgaanbieder identificatienummer | 99901111 (in identificerend systeem: URA) | |||
| Organisatie naam | Apotheek Jansen en Co | |||
| Zorgaanbieder Ziekenhuis_het_Gele_Hart | ||||
| Zorgaanbieder identificatienummer | 00004444 (in identificerend systeem: URA) | |||
| Organisatie naam | Ziekenhuis het Gele Hart | |||
| Adresgegevens | Werkadres: Groenestraat 1 1200AA Hartstad | |||
| Organisatie type | Ziekenhuis (code = 'V4' in codeSystem '2.16.840.1.113883.2.4.15.1060') | |||
1.10 Patiënt H. XXX_Hoek[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | H. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hoek | |||
| Identificatienummer | 999900638 [BSN] | |||
| Geboortedatum | 5 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.10.1 Medicamenteuze behandeling MBH_300_contactepisode[bewerken]
| Medicatieafspraak MBH_300_contactepisode_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| Medicatieafspraak datum tijd | T - 20 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 9 dagen | |||
| Ingangsdatum | T - 20 dagen | |||
| Einddatum | T + 9 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 2 stuks | |||
| Relatie contact | ||||
| Identificatienummer | MBH_300_contactepisode_CONTACT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | |||
| Relatie zorgepisode | ||||
| Identificatienummer | MBH_300_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200) | |||
| MBH identificatie | MBH_300_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Wisselend doseerschema MBH_300_contactepisode_WDS_opstartschema | ||||
| Gegevenselement | Waarde | |||